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ABSTRACT
The mycotoxin Ochraloxin A (OTA), is 1I widcsprc;ul C0I1I:1111i11anl of cereal.~.
beans and meat products. Its solubility in the aqueolls phase depends Illl iOl1ization ur the
phenolic hydroxyl group whose pK, was found to be 7.05. 1~\rJi.:r rese;lrcher.~ have
demonstrated Ihe importance of the portal venous route in OTA "bsorptilln. Ahsorption
in the presence of lipids is of interest because lipids form a signillcant pmpurtillll or the
diet in countries where OTA contamination occurs. When OTA was administered tn
conscious rats in corn oil mther than in sodium bicilrbonate, the lymphatic mute played
a greater role in the transport of absorbed OTA. In lhe absence of hile. OTA tr;lIl.~porl
in lymph was not increased even in the presence of corn oil, suggesting that OTA
handling by the lymphatic route depends on micellar solubili7.ation in mixed hile salt/lipid
micelles. When carried in lymph, OTA reaches the general circulation without being
subjected to "first-pass" hepatic metabolism.
Key words: ochratoxin A; nephroloxin; lymphatic transport
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Introduction
The mycotoxin Ochrntoxin A (OTA) is a widespread contaminant of cereals,
beans and meat products. It poses a risk to the health of animals and humans, and has
been linked to the fatal kidney disease, Balkan endemic nephropathy. This thesis
addresses the mode of absorption of OTA and the effect of pH changes on its ionization
state ar.d solubility.
I. TilE ROLE OF FUNGI (1,2,3]
1.1 Biology of Fungi Fungi are eukaryotic organisms which, unlike green plants, do
not possess chlorophyll. They are unable. to synthesize from CO2 and H20 the organic
compounds they require for growth and reproduction, and therefore depend on other
organisms to supply the nutrients they need. They establish themselves on a host, which
may be living or dead, and either absorb compounds intact (in the case of
rnollosnccharides or amino acids) or secrete extracellular enzymes which degrade
nutrients to simpler constituents which can then be absorbed. Fungi are composed of
threadlike tubular structures, hyphae, which form extensive anastomosing systems called
mycelia.
There are approximately 50,000 species of fungi, ranging from unicel1ular yeasts,
moulds, mildews, nlsts and smuts to lichens and the larger fungi such as mushrooms.
Classification of fungi is not straightforward: the initial distinction is made on the basis
of presence or absence of a cell wall, and a further disHnction is based on whether
reproduction is sexual or asexual. The genera Aspergillus and PCllicillilm/ fall within a
group of~ (fungi with walls) which reproduces almost l..,tltin."Iy by ml..'allS of
asexual spores, known as conidia. These slnlClures fonn ~xl..:mal1y on Ih~ hYllha~, (lr
on modified hyphal branches. ASfWry,illfI,f and f't'lIidllillll/ arc classified either und~r
Qeu!emmyroJjna which only reproduce asexually by means of conidia. or under
~. which OCC4\sionally will also undergo sexual reproduction wilh th..: formation
of ascospores. When conditions are not favourable to a fungus, it may move inlo an
essentially dormant phase, producing dry, spore-like struclures c"lIed sclerotia. Whcn
conditions improvc, the sclerotia germinate and the fungus reSUlllCS active ll1cl~bo1ism,
In the life of fungi. there arc several essential stages: sJlore gcrmin;uinn;
vegetative growth of the mycelium; development of the sJlOre-bl..'aring struclures; alld
liberation of spores. Metal>olism, using organic cOlllJlOunds -Icrived frum oIlier
organisms, generates energy in the form of adenosine triphospll.'\tll (AT!'); provide-'i
reducing power for biosynthetic reactions, usually in the form of reduced eu-cn...ymc.... ;
and provides intermediates for a range of biosynthetic pathways. R(.'gulalion of glucose.
metabolism is of major importance. II is achieved through keyen1.ymcs, in response 10
the availability of nutrients and trace elements such as zinc and manganese, amI hy
feedback inhibition by end produCIS.
1.2 Secondary metabolism and mycotoxins If excess carbohydratc is availahlc aftcr
growth of the fungus has ceased due 10 shortage of a requircd nUlrient (commonly a
source of nitrogen), the fungus may switch into secondary metabolism. Certain Sir-tins
of fungi arc. particularly prone to make this switch. Relationships between the pathways
of primary and secondary metabolism are shown in Figure 1.1. Secondary metabolites
arc derivatives of many different intermediates of primary metabolism, and can be
classified according (0 five major sources: glucose-derived metabolites including some
polysaccharides, peptidopolysaccharides and sugar alcohols; polyketides and phenolic
compounds derived from the condensation of acelate from acetyl·coA in the acetate·
malonale pathway of fally acid biosynthesis; steroids and terpcnes derived from the
condensation of acetate from acetyJ·coA in the mevalonic acid pathway; phenolic
compounds derived from the shikimic acid pathway for the biosynthesis of aromatic
amino acids; and various ol!lcr pathways of amino acid synthesis. The amino acids
involved in the synthesis of secondary metabolites originate from many slages in
glycolysis and the Krebs cycle. TIle shikimic acid pathway uses erythrose phosphate
from the hexose mooophosphale pathway and phosphoenolpyruvate derived from
glycolysis. The function of products of secondary metabolism has been the Sut-jecl of
much speculation. Some secondary metabolites playa role in tnc normal physiology of
the fungus, c.g. compounds in the isoprenoid group behave as hormones influencing
sexual reproduction in many fungi. It has been suggested that the secondary pathways
nrc safety mcchanisms which prevent accumulation of harmful intermediates of primary
melOlbolislll during periods of nutrient imbalance [4]. Some secondary metabolites are
aclivc as antibiotics against bActeria; this may provide a competitive advantage to the
fungus. Many secondary mctabolites possess toxic properties and are known as
Figure 1.1
Interrelationships between plllh\\'ays of pdnmry and secondary metabolism
The principle pathways of secondary metabolism ar~ numbered (I) to (5)
(I) glucose-derived metabolites
(2) acetate-malonate pathway
(3) mevalonic acid p..1thway
(4) shikimic acid pathway
(5) amino acid-dcrived pathways
For simplicity, many intermediates have been omittcd, and arrows point ill one
direction only, although many of the reactions arc reversible. Thc incorporation
or production of COl in somc reactions is nol shown bUI Illay be inferred rrum II
change in the number of carbon atoms.
Adapted from Deacon J.W. [2J and Grimn D.H. 131
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mycotoxins: this term is usually reserved ror toxins sl'Cretcd lly rungi which Imve
invaded reed and foodstuffs.
The word mycotoxin has an interesting derivation. It willes from the Greek mots
p.UKtjf;, meaning mushroom, and TO€IKO<;, which originally referred tll i\ hllw or amlw and
by association with arrows tipped with poison came to refer Itl the POiStlll itself. The
root "ochra" in ochTiltoxin comes fromthc Greek wXW~, meaning yellow ur pale yellow.
often related to corn.
1,3 Historical Background Fungal cO'llamination of crops has hL'C1l rccogl1izl'(l fur
centuries. Mildew is mentioned several limes in Ihe Bible 151. amI In Ihe works of
classical authors such as Xenophon (6], Plato (7] and ThCl:lphmstlis pq. Opinioll was
divided as to whether it was divine retribution for wrongdoing, tIT an accidcnt due tll
disturbances in the motion of the Sl<lrs. Pliny (9) claimed that sueh damitge Itl crops
was only caused when there was a ful1111oon. Plato [IOJ regardl'd mildew 1 as an evil
specific 10 grain. Lucius Junius [111 advised that certain crops, in particular harley,
were better hoed when dry so that they would not be aHacked by rust 1. He alsn
suggested that when the weather was unseasonably cold, the smoke fmm fires lit hetwccn
I E.pua[{3",. mildew orrUSl in cum.
2 Rubigo. inis (t): rust. in the agrkultural senst.:. This woru hints al ,I ro:ddish quality
(a meaning transft.:rrt:tl from the rust of imn) hUI indllllc.~ ;ut.:as such as hlight. milllew,
smlltand mouldinllSs).
the vines would protect against fog and mildew [12]. These references give no
information as to the effects on animals or humans of consumption of mouldy crops, and
probably referred to a whole spectrum of fungal infections.
In 1928, Larsen linked kidney disease in swine wilh consumption of mouldy rye
[13J and over the years ftmould nephritis" has been recorded on a regular basis in
Danish slaughterhouses [l4J. Balkan Endemic Nephropathy (BEN) had been known
in Bulgaria and other Balkan countries for years before Ivanov started animal experiments
in 1950 to try to shed some light on the causes of the disease [15]. In 1956 Tanchev
published the first formal description of BEN, describing the high incidence of renal
disease in northwestem Bulgaria [16]. The first report of OTA, together with its
structure and physical and chemical properties, is found in a leller to Nature in March
1965 from van der Merwe (!( af. [17J. They described the laboratory production of
OTA using strains of A.rper8i/lwi ocl"acCII.f grown on moist corn meal, and noted that
consumption of the mouldy meal caused rapid death in ducklings, mice and rats. Since
that lillie many reports have been published, confirming the association of OTA
contamination of food and animal feeds with the incidence of BEN, and noting the risks
to human al1d animal health in many countries, including Germany, Poland, Romania,
lhe former Yugoslavia. the U.S.A. and Canada. Other studies have focused on lhe
distribution of ingested OTA, and its metabolic handling. In spite of more than thirty
years work on this mycotoxin, its mode of action is ollly incompletely understood and
it continues to pose a risk to human and animal health.
1.4 Factors which promote fungal infections in crops Fungal infections arc a noruml
occurrence in crops but the prolile and severity vary from ycar to year according to field
and storage conditions, with complex interactions between temperature. humidity lInd
availability of trace elements such as zinc, iron and copper. The presence of dehris ill
stored grain interferes wilh drying, and damaged and immature SL'Cd is more susceptible
to fungal damage. Crops infected by fungi deteriorate in nutritiOllal quality and uften
become discoloured. There may be "hot spots" in ston.'d grain, with a rise in
temperature and a fall in pH [18]. The crops may smell mouldy ami animals milY find
their feed less palatable.
I.S Ochragenie Fungi Of the fungi which produce OTh, Aspl'f~iII//.I· species tend to
predominate at lower moisture levels (16% humidity) and a higher temperature range
(8 - 37° Celsius, optimum for OTA production being 31 ~ 37°), whereas 1'1'lIidlliwlI
species predominate at higher moisture levels (20% humidity) but lower temperatures
(range 0 - 31° with maximum OTA production at 16 - 24° C) [14]. Sometimes fungi
produce more than one mycotoxin, e.g. certain strains of Aspl'r1:iIIus m'l/rUCCI/.I· can
produce both penici1lic acid and OTA; the balance bctwt:cn the lWO depends on
temperature [19] and humidity [20], lower temperature an~ moisture favouring
production of penici1lic acid. One laboratory study [21] comparing the mycotoxins
produced by A. alutacells (formerly A. ()c"ru(·eu.~) an~ P. verruco.mln growing on
oilseeds (soybeans and peanuts) or grain crops (corn and wheat) showed that A. a/ult/Cel/of
growing on oilseeds produced more OTA than it did when growing on grain, whereas
P. verruco.rum produced more OTA when it was growing on grain rather than oilseeds.
Ochratoxin B, the non-toxic dechloro form, was only produced by A. ochracelfs on
oilseeds (particularly soybean) and another related mycotoxin, citrinin, was only found
in this study when P. verrucWjum grew on com or wheat. Another factor influencing
fungal growth is aeration. Fungi arc aerobic organisms and alterations in levels of
lItmospheric gases, such as might be found in bulk storage conditions, affect the balance
of metabolic processes. One study demonstrated relatively high levels of OTA
production in a static submerged culture of A. ochraceus, but no toxin production in an
aerated culture under otherwise identical conditions [22}. Taole 1.1 lists species of
storage fungi known to produce ochratoxins [231.
Table l.t
Species of storage fungi known to produce Ochratoxin A
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Aspergillus
a/II/m:ells I ochrac:eus ~
ostia/1l1s
me/feus
petrakii
.~c1erofillm
slIlpllllreus
ul/iacills
• Common in western Canac.la
~ Also produces dtrinin
Taken from Marquadt. Frohlich amI Ahramsun 1231
Penicilliutll
W~I"I"IIC:{/Slllli ~ ~
lydOl,ill/ll ~
dlly.\'O/!.f'llll/l/
Pulil/III,I"
ptlrpl/r(',\'c('ns
vfI!'iable
2. OCHRATOXIN A
2.1 Structure and Chnracteristics of Ochratoxin A. OTA is described chemically
as 7-carboxy - 5-chloro - 8·hydroxy - 3,4-dihydro • 3R methylisocoumarin
linked through the carboxyl group to L phenylalanine. The structure of OTA is
shown in Figure 2.1. Other members of the ochratoxin group include the less toxic
Ochratoxin B, which lacks the chlorine atom at position 5; Ochratoxin C, the ethyl
ester, which appears to be just as toxic as OTA; Ochratoxin D:, the non-toxic
hydrolysis product of OTA, which lacks the phenylalanine moiety; and the
hydroxylated metabolitcs, (4R) and (4$) 4-hydroxy OTA, and 10·hydroxy OTA.
OTA, and rarely, Ochratoxin B, occur naturally in foods of plant origin. The
hydroxy mctabolites and Ochratoxin a have been found in urine of animals which
have ingested OTA [24J.
OTA is a colourless, crystalline compound of molecular weight 403.8. When
obtained by crystallization from benzene, it has a melting point of approximately
90"C, but with drying at 60 0 for I hour, benzene of crystallization volatilizes and the
melting point is then about 170". It is soluble in chloroform, xylene, benzene,
methanol and ethanol, and aqueous solutions at alkaline pH. The UV absorption
spectrum varies with pH and solvent polarity: in ethanol, maxima arc present at
213 nm (f = 36.8 IllM· I) and 332 nm (E = 6.4 mM· I). In methanol, with excitation
at 340 nm, the fluorescence emission maximum occurs at 465 nm [25}.
The pK, of the phenolic hydroxyl group at position 8 ofOTA was identified as
7.1 by Pitout [26J who observed the shift in absorbance of OTA in phosphate buffer
COOH O¢OH0Ii.U- CH,-CH-r-C '0 ? H~ H , • ':.CH
J
CI
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FlIUre2.1 Tht strudurt of Odtratoxln A
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with changing pH. Chu [27J used OTA in KCIIHCl solution and found the pK.
of Ihis group to be 7.04. On the other hand, Gallier el af. reported two constants,
pK , at 6.75 and pKf at 10.25. which they attributed to the carboxyl and phenolic
groups respectively [28].
2.2 Biosynthesis of OTA. The mycotoxin which is the subject of this thesis is a
secondary metabolite of strains of various species of Aspergillus and Penicillium.
The biosynthesis crOTA was studied using p4C]- and ['lC]-labeled precursors.
II was shown that [14C]-phenylalanine labelled at C1 was incorporated into OTA
by cultures of A. ocltracells [29]. Hydrolysis of the labeled OTA with 6N
hydrochloric acid gave the isocoumarin moiety and L-phcnylalanine. All of the [14C]
label was found in the amino acid. It was then shown that the isocoumarin moiety is
formed viti the acetate-malonate pathway from one acetate and four malunate units,
<lnd the c<lrbonyl carbon atom (CI2) is derived from the Cl pool [30], Incubation of
A, m.:/iI'Ucell.l' in a medium cunlaining [l6CI]_labeled sodium chloride resulted in the
incorporation of 0.75% of [lloCI] into OTA [31], but it is not known at what stage
the chlorine alom is introduced. An outline of the biosynthesis ofOTA is shown
in Figure 2,2 [32,33].
2.3 Crops I1t risk from ochragcnic fungi Ochrap:nic fungi can infect a variety of
crops including maize [34], wheat [35] and barley [36], rye [13,37] and
sorghum [38], oil seeds, beans [39] and rice [40].
oH3C-~~ S-CoA
acelylCoA
acetate/malonate
paltway
o
"
eOOC-CH;z -C!- S-CoA
malonytCoA
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, (a"'~1 CoA) + 4(",,'onyl CoA) ••• ----------~
~
CI
Ef)'1h"Ose4.p +PEP
H~O
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~COOI CI
V NH, /
phO""'..... ~
~oo1J,J..oU --~ 6~
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Figure 2.2 Biosynthesis of Ochratoxin t\
Adapted from Yamazaki et af. 132J amI Vh:ga;lr amI Stcyn 1331
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2.4 Odlratoxin A contamination of foodstuffs Sampling of foodstuffs is
un.~ertakcn in two ways: either at random, or specifically directed towards clearly
suspect items. The incidence and levels of OTA contamination reported are therefore
likely to differ depending on sample selection. Tables 2.1 and 2.2 give examples of
recent occurrences of OTA conlaminalion in foods of plant and animal origin, with
the criteria for sample collection made clear whenever possible. It is not possible
from appearance alone 10 be certain that food products are free of contamination: if
pigs or chickens are given feed contaminated with OTA, they may not necessarily
exhibit symptoms of disease and there may be no obvious macroscopic lesions which
would lead to rejection by health inspectors [41]. In spite of this, meat and meat
products from these animals can contain measurable amounls of the toxin [42J.
2.5 Stability of Ochratoxin A arA is remarkably stabk whether in cereals, beans
or animal tissue, even after prolonged storage, processing or cooking [43,44].
Cleaning and milling of wheat and barley did not remove OTA in naturally
conlaminated samples [36]. Ammoniation (2% NHJ at 45· for 6 weeks) effectively
decomposed arA without affecting the nutritive value of the grain, but rats found the
grain unpalatable [45]. Although"t irradiation may have some application in food
processing to reduce OTA levels in meat products (46], protection from the toxic
effects of OTA is best achieved by preventing the damp storage conditions which
favour its production [18,19]. In Denmark, only in normal or dry years can the
level of OTA contamination in cereals be kept below 10 ~g/kg [47).
Table 2.1
Recent- instances of natural occurrence of OTA in 1)lllllt IJrodllcts
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Product Coulltry Incidence (OTAJ(ng/g) Ref.
Maize (1984-1990)
(from area wilh emJemic Buillaria 89fJ51 0.2-14111 1481
humannephrollalhy)
(fromnon-enl.l<lmieaR'll) Bulgaria 14f113 0.2-235 1481
Beans (1984-1990)
(from enllemic area) Bulgaria llfl47 0.05·264 14111
(from non-t:m.lemic lreal) Bulgaria Illt!) 0.20-285 '481
Wheatanl1b1lrlllY Canada 51440 10-51 1491
Fe.:d~ Ilnd fllet1 Grain (~uspecl) Canada 4151 48-5,900 1501
"', Frnnre 4/37 5-110 1511
Barley Gerrrumy 10/68 0.1-206 [521
Wh~' Gernlllny 1521
RDlsledcoffetl Japan Sf68 3.2-17 1531
OlivesnmJolivcoil Morueco 8fl63 40·80 154J
Cereals Polan<! 61100 up In lWO 1.'151
Wheatlllld rye llour PolllrKl 481215 nll.:lln4370 15(,)
Com oil U.K. ,n 1l·50 IS7J
Breakfaslcereals U.K. 12/243 <1O-SO 1571
Beans (emltmicarea) YUttlJSlavia 4(50 17-053 1581
* 1980 onwards
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Table 2.2
Recent· instances of natural occurrence of OTA in meat and meat products
Product Country Incidence [OTA}(ng/g) Ref.
I·jgkitlnqs(wll) Denmark 0.01596 of >25 1591
(1986-1990) 80l1~
rig ki,jl1cy~ D~nnUlrk 18.4~of >2S 1591
(ncphmpulhic) (1986-1990) 6S.2xW
BlllckptllllJing Germllny 201125 0.1-3.4 1601
UwrSllu""l:c Germany 19/100 0.1-3.4 1601
Pigkillneys U.K. 431278 1-44 161)
Meatl'llI,Jucls U.K. 7/33 upt1l4 162)
SmokcoJ melIls and Yugoslavia 12-29~ 10·920 163)
~a\llillgCll
.. 1980 onwards
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2.6 Toxic Effcds of Ochratoxin A. Toxicity of OTA depends on the presence
of the phenylalanine moiety, and on the chlorine atom at position 5 (Pigurc 2,\).
Ochratoxin B which lacks the CI is much less toxic Ihan OTA, and Ochratoxin a is
not toxic. Ochratoxin C, the ethyl ester, which has not been shown to occur under
natural conditions, is as toxic as the parent OTA.
OTA, the mosl abundant ochratoxin, is toxic to a wide variety of organisms
from bacteria to mammals [64J. The acute toxicity to some spccic.~ is listed in
Table 2.3 [65,66J. OTA is nephrotoxic, hepatotoxic, carcinogenic. mutagenic,
teratogenic and immunosuppressive [67]. It disturbs calcium homeostasis 168}
and damages membranes by lipid pcroxidation [69]. After oral ingestion. OTA has
a long biological half-life in mammals, ranging from 39 hours in the mousc to 120
hours in the rat and 510 hours in the Rhesus monkey [70). This is a consequcnee
of the strong binding of OTA to plasma proteins which in mammals has been shown
to be greater than 99%. Chu [27] used equilibrium dialysis and gclliltralion studies
to show that 2 moles of OTA were bound to I mole of bovine serum albumin.
Stojkovic ef af. [71] have proposed that OTA binds in a non-specific low affinity
manner to serum albumin, but with much highcr affinity (by several orders of 10) 10
a group of low molecular weight (approximately 20 kD) serum macromolecules.
Albumin is present in the serum in high concentration, and so acts as a large mobile
store of OTA. The serum concenlration of the 20kD molecules is much lower than
that of albumin, but specific binding of OTA to these smaller macromolecules would
allow passage of bound OTA through the glomerular membrane, thus delivering OTA
Table 2.3
Acute toxicity of orally ingested Ochratoxin A
Species LD5lI mg/kg
46.0-58.3
rnl 20.0-30.3
ratnconale 3.9
dog 0.2
pig 1.0
chicken 3.3
Based on literature compilations by Harwig et al. (65) and
the National Institute of Occupational Safety and Health [66]
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\0 its prime target organ, the kidney. OTA specifically damal!-cs the proximal
tubule of the kidney conex, impairing the anion transport system [411. A measu!"C
of this damage is given by the T.ol'AU f C in ratio, which is reduced In OTA toxicity.
TtlIl'AH represents tubular excretion of a lypical anion. pam <tminohippuric ncitl, and
C.. represents glom~rular filtration. using inulin as a standard COIll\Xmll(] which in
normal renal function is found in the filtrate. There is glycosuria. proteinuria and
decreased ability to concentrate urine. Renal gluconeogenesis is imraircl] (JIlC 10
inhibition of phosphoenolpyruvate camoxykinasc [72]. Inhibition of protc1n
synthesis by OTA is seen in bacteria as well as higher organisms. Phcnylalanyl
lRNA synthetase is blocked by the OTA molecule; prolein translation and synthesis
are impaired [73,74]. The mechanism(s) whereby OTA depresses immune
function are not known, but both the inhibition of protein synthesis and the
immunosuppression caused by QTA are prevented or at IClIst l1linil11i:t.cd by the
concurrent administration of phenylalanine (75,76J.
2.7 Geography of Och ...lloxill A cOlllaminalioll Health consequences for humans
are clearly seen in the Balkan countries Bulgaria (Vratza District), Romania (Ballill
region) and the former Yugoslavia (particularly districts in Serbia, IJosnia and
Croatia, notably near the city of Siavonski Brod) [77,78,19) (rigure 2.3).
Affected areas arc located along tributaries of the Danube; most arc at relatively low
altitude (100 - 200 rn) and arc often noodcd. Significant levels of OTA have also
been detected in food of plant and animal origin in other countries (Tables 2. J, 2.2).
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loigun! 2.3 The Balkans and the river Danube
Adapted, with permissioo, from American Sciemist [SOJ
2.8 Human Exposure and evnluation of risk It is clear that humans in Illany
countries are exposed to OTA. Table 2.4 gives details of human serUlll OTA levels
reponed in recent studies in different countries including Canad'l. OTA has also
been found in trace amounts in human milk in Germany [81] and Italy [82J. and
in human urine in Bulgaria [83]. Balkun endemic nephropathy, mentioned earlier
in this review, is strongly linked to OTA contamination of crops {39,84]. Other
mycotoxins such as citrinin may be also be involved, exerting synergistic effecls
with OTA [48].
Kuiper-Goodman and Scott [85] using data from the National Toxicology
Program {86] study of carcinogenesis in rats applied a safety faclor and arrived at
estimates of 0.2 • 4.2 nglkg body weight as the tolerable daily limit of cOllsumptinn
in humans. This is lower than levels identified as virtually safe with respect to
nephropathie and teratogenic effects; in 1991 the Food and Agriculture I World
Health Organization suggested a provisional weekly tolerable dose of 112 ng/kg
body weight [87].
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Table 2.4
Prevalence of orA in human serum
Vear(s) Country Detection limit Positin Range Ref.
_gig samples _gig
1984·1990 auf,.ria: 1.0-2. 28110S 2.0-]9.1 188)
intlivi.JUl.I~ with
B.e.n.oru.l.I.
Bu1l:lfia: 1.0-2.0 181119 2.0-20.0 [88)
heallhyrd.liv.=.~
ofthlllbovll
1984-1990 Bull:lria:ht:lllihy 1.0-2.0 14/116 2.0· 13.0 [881
pwplllin arr.:ch:d
vllllll:lIS
1984- 1990 Bull:lria:llealthy 1.0-2.0 91125 2.0-15.0 [88)
peorle in non·
cndcmiell'Cll
1990 c.n.J. < 0.5 28169 < 0.5· >20.0 (89)
M1bjc:clJwilh
rtnIldi_
1990 """",,, < O.S 3"'0 < 0.5 - >20.0 (891
lUb:jeclswilhoul
"",.Id~
1986-19&8
"""""'"
0.1 78/144 NO- 13.2
'''''!'l:f'Orto:tl 1991 FI1I~nlllll 0.2 220. 0.1-6.0 (91)
rq>nrtcdl991 FI1lIlI;C; um.n 0,·, 20.155 0.1-1.3 191)
"'l"oulooI986 GCIll1llll)':B.~ S6.S'iIo 0.1-14.4 [""
1983-[984 Poland S.O 7711065 NO- 40.0 [56'
1989 S~cn: 0.3 4.0-8.0W. 0.3-6.8 [""
urhan,ltlIinlanll
1989 Sweden: Vishy· 0.3 31.0' 0.3-6.0 1901
islandrommllnit)'
1981-1989 Yll~osllVil s.o 200113797 5.0-100.0 192]
B.e.n. rJeooles Iblkln endemic Ael"hropathy, u.u., urinal)l t~1 tumOUQ. ND - not detected
3. ABSORPTION OF FOREIGN COMPOUNDS [93]
3.1 Routes of absorption There are three main barriers which scparal~ higher
animals from their environment: the skin, the lungs and the gastrointestinal tract.
To date, there have been no report~ of OTA assimilation via the skin or the lungs,
although in principle absorption by either of these routes might be feasible. This
account will only consider absorption via the gastrointestinal tmct. 'nle major
function of the digestive tmct is to absorb nutrients and water, but non-nutritive
compounds such as food additives, preservatives, drugs and cOlltamilH\Ilts are
often ingested and absorbed along with the diet.
3.2 Toxic compounds in foods Toxic compounds oftcn contmllinate animal and
human foodstuffs, sometimes naturally, sometimes by accident and sometimes by
deliberate action [94]. A few examples will be given to illustrate some of the
various ways in which toxins find their way inlo foodstuffs. Some plants natumlly
contain toxic compounds, e.g. cassava, a tuberous root vegetable found in South
America, contains cyanide. Fungal infections of crops can result in contamination
of foodstuffs with toxic metabolites: the most well known are the aflatoxins which
are frequently found in mouldy corn and peanuts. Aflatoxin M1 has been identified
in the milk of cows whose feed contained aflatoxin BI . Aquatic species such as
shellfish may contain natural toxins originating from the plankton they consume.
Contamination of foodstuffs can occur accidentally, as with pesticide residue.~, or
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deliberately, ~.g. the toluidine-oontarninated oil sold in Madrid in the early 1980s
[95]. Man-made pollution often contarninates food: industrial effluent discharged
into some lakes and rivers has resulted in a dangerous mix of organic chemicals and
heavy metals whose effccts are seen in maUormations in fish, and binh defects and
neurological disease in humans [96,97]. Carcinogenic polycyclic aromatic
hydrocarbons are ubiquilous contaminants wherever petroleum prodU<:IS are used.
The surface layers of foods which have been smoked, or cooked at high temperatures
over abarbecue contain a number of carcinogenic substances. Nitrates and nitrites
used in preservation of meat products are ultimately carcinogenic, so while offering
protection against bacterial spoilage they probably pose a longer-term hazard to
health. Although generally speaking our food supply is safe and nutritious, these
examples show thai. xcnobiotics can and do contaminate both human and animal
foodstuffs.
3.3 Absorption: gencnll principles (98,99) Mecbanisms of absorption vary
wilh the chemical cha.racteristics of each compound, in particular with size and
lipophilicity. The ma.jority of toxicants cross membranes by simple dirfusion. Small
hydrophilic molecules such as ethanol and cyanide pass through aqueous pores in
membrnnes, and are rapidly absorbed from the stomach and intestine, but most toxic
substances are larger organic molecules wilh differing degrees of lipid solubility. The
more lipid-SOluble a compound is, the more readily it will cross lipid membranes.
2.
3.3.1 Weak acids and bases Many chemicals arc weak acids or bases which ionize
in solution according to their pK and the prevailing pH. This concept is cxprc.~scd by
the Henderson-Hasselbalch equation:
for acids: pK. - pH :::> log [non-ionized] I (ionized]
and for bases: pK" - pH '" log [ionized) I {non-ionized]
By definition, when the pH is at the pK value, the non-ionized form of a weak acid or
base is present in the same concentration as the ionized form. Depending on how fliT
is the prevailing pH below the pK value. a we.1k acid will be more or less protonatl.'d
and non-ionized; as the pH rises above its pK. it will become further ionized and
more soluble in aqueous media. The non-ionized form of weak acids and b.1SCS is 10
some extent lipid soluble, allowing it to diffuse across lipid membranes. We have not
been able to find any repons concerning the solubility of OTA in lipids, but given its
solubility in organic solvents, it is likely that it is at least partially soluble.
A weak acid such as benzoic acid (pK, 4.0) diffuses more rapidly across a
membrane if the prevailing pH is acidic, whereas a weak base such as aniline (pK,
5.0) which is non-ionized above its pK. diffuses more readily from lin alkaline
medium. Even so, because absorption is a dynamic process, if only I% of a
compound is non-ionized at a a given pH (e.g. benzoic acid al pH 6.0) some of thai
1% will diffuse across the lipid membrane. If the compound is removed from the
intracellular side of the membrane, a concentration gradient will exist and diffusion
across the membrane will continue. The extent to which simple diffusion will take
place depends on surface area, permeability of the membrane, the prevailing pH
and the physical characteristics of the compound. Because the small intestine has
a large surface area. benzoic acid is well absorbed, even at a pH which might be
considered unfavourable [94].
3.3.2 Olher radars affecting absorption Gastrointestinal motility and the
length of time food slays in various segments of Ihe gut also influence absorption.
111C presence of fat in a meal delays gastric emptying; dilution of some compounds
increases toxicity, probably because increased volume hastens gastric emptying,
resulting in more rapid delivery 10 the duodenum and consequent exposure to a
greater absorptive surface [100]. Laxatives may reduce absorption by speeding
intestinal transit lime [101]; a high fibre diet also speeds the passage of food
through the gut. Fibre binds water, and adsorbs important minerals (calcium, iron,
magnesium and zinc) and bile salts and lipids, thus reducing their bioavailability
for absorption. This may lead to deficienci.e~. of essential minerals and fat-soluble
vitamins, and may also reduce absorption of some toxins.
3.3.3 Spctializcd carrier systems The mammalian gastrointestinal tract has
specialized carriers for the absorption of monosaccharides, small peptides and
free amino acids. There are also specialized transport systems for the absorption
of calcium and ferrous iron. Some toxic substances may be absorbed by these
systems, t'.g lead and cobalt are transported by the calcium and iron transport
systems. Most toxins however are absorbed passively,
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3.4 The stomach Although small molecules such as waler and ethanol arc
absorbed, and some important digestive processes stan in the stomach, it is IlOl
primarily an organ of absorption. A striking featun: of the stomach is the regulation
of pH, which is achieved through neural and hormonal mechanisms. When Hel is
secreted in response to a meal, the pH of Ihe gastric juice is :=: 1.0. Food buffers
the luminal pH, which may rise to 4.0 or even 5.0; if the pH ill the distal portion of
the stomach falls below 3.0, secretion of gastric juice is reduced. If acid rc..\chc.~ the
upper small intestine, gastric secretion of Hel stops. Mucus provides a protcctive
layer for the stomach mucosa, creating with basal secretion of bicaroonalc a pH
gradient between the surface mucosal cells (:=:pH 6.5) and the contents of Ihe IUlIIen.
Gastric emptying is regulated according to the composition and osmolarity of Ihe
food mixture (known as chyme). Liquids leave the stomach lint, followcc.l by
carbohydrates, then proteins and lastly fau. Emptying is delayed in response to low
pH, and the presence of long.chain fatty acids and their mono- and diglyccridcs. A
mixed meal including fats probably Slays in the human stomach for about 4 hours.
3.5 Digestion and absorption in the small intestine The small intestine presents a
vast surface over which absorption takes place. It is divided arbitrarily into three
segments: the duodenum, the jejunum and the ileum. Like the digestive tube in other
regions of the gastrointestinal tract. the wall of the small intestine has four main
layers: the serosa, the muscle layer. the submucosa and the mucosa (Figure 3.1).
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3.5.1 The mucosa The mucosa will be described in detail because it is the site of
absorption. It can be divided into three layers: the muscularis mucosae (a thin sheet
of muscle), the lamina propria, and the epithelium. The mucosal epithelium consists
of columnar absorptive cells known as enterocytes, with interspersed mucus-secreting
goblet cells and endocrine cells. The surface area of the mucosa is made much
greater by circular folds (in larger mammals only), by villi (Figure 3.1) and by
microvilli (Figure 3.2). The villi project into the lumen at a density of ten 10 forty
per square millimetre. Each absorptive cell has between 3,000 and 7,000 microvilli
which make up the brush border seen on light microscopy. In the human, the
microvilli are approximately I ~m long and 0.1 ",m broad. Figures 3.3, 3.4 and 3.5
are electron micrographs showing the intestinal epithelium and the microvilli. The
plasma membrane of microvilli is a lipid bilayer, containing many specialized proteins
such as enzymes, transporters and receptors. The enzymes of the brush border are
glycoproteins, with the protein component to a greater or lesser extent embedded
into the lipid membrane of the microvillus; the carbohydrate chains protrude into
the lumen, forming lhe glycocalyx (Figures 3.2, 3.5). Next to this is a protective
layer of mucus. Barriers to absorption of compounds are discussed in 3.5.11.
The basolateral membrane of the absorptive cell is thinner and more permeable
than the luminal membrane; passage across it occurs by diffusion.
Figure 3.1 Anlltomy of the SIIIl1J1 intestine
The wall of the mammalian intestine is composed of four concentric layers.
Three outer layers ~ the serosa, the muscularis (consisting of longitudinal and
circular muscle strata), and the submucosa· surround the innermost layer,
the mucosa. The surface area of the mucosal epithelium is vastly inereascd by
villi and microvilli, to about 300 m2 in the human. Inside each villus is a
dense network of blood and lymph vessels to which nutrients are transported.
From: The Lining of the Small Intestine by Florence Moog [102].
Copyright C November 1981 by Scientific American, Inc. All rights reserved.

Figure 3.2 Structure or the absorptive cell
This figure shows diagramatically the important structures of the absorptive cell.
The glycocalyx. is composed of the carbohydrate chains of enzymes embedded in
the microvillus membrane. The shape of the microvillus is maintained by protein
fibres which run throughout it.~ length; these fibres join with the terminal web,
a mesh of fibres running parallel to the luminal surface of the cell.
From: The Lining of the Small Intestine by Florence Moog [102].
Copyright C November 1981 by Scientific American. Inc. All rights reserved.

Figure 3.3
Eledron microgrnph of inieslilllll cl>ithelilil cells aud :1 goblcl cell
x 5000 The goblet cell (G) is packed with mucous secretory granules at the
apex. Note the Golgi apparatus oetween the nuclcus and the mucous granules.
By permission. Springer·Verlag New York Inc. [1031

Figure 3.4
Electron micrograph of epithelial cells from the apiclll one third of a villus
x 10000 Note the tall columnar epithelial cells, nuclei N, brush border n,
supranuclear Golgi complex G, intra-epitheliallymphocyle I, terminal web T.
By permission, Springer-Verlag New York Inc. {104]

Figure 3.5
Electron micrograph of the apical portion of two adjacent nbsorptive cells during
fat absorption x 25000 Note the surface coat (glycocalyx) S, Illicrovilli MV.
secretory vesicle V, absorbed lipid F, mitochondrion M, and the apical pit (arrowed)
at the base of microvilli, where ferritin but not fat is absorbed.
By permission, 1. B. Lippincott and Co. [104)
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3.5.2 The lamil!.'! propria The lamina propria consists mainly of connective tissue
which supports the epithelium, and forms the core of each villus. Within Ihe villus is
a central lymph collecting vessel, the lacteal, surrounded by a nt:lwork of cilpillarics.
figure 3.1. Also found in the lamina propria are small lymphocytes and lymphoid
nodules. These form part of the GALT system· the -gut-associated lymphoitilisslic"
- which is a major subdivision of the immunological defences of the lJody.
3.5.3 Pancreatic Juice Pancreatic juice contains enzymes and electrolytes, notably
bicarbonate. When stimulated, the pancreas secretes sufficient bicarbonate to
neutraljze all the titratable acid reaching the duodenum from the stomach, thus
providing a pH suitable for the digestive enzymes active in the lumen.
3.5.4 Digestion and absorption of carbohydrates Complex carbohydralc.~ arc
hydrolysed enzymatically to simple sugars which arc transported by carrier-mediated
systems across the cell membrane. From the enterocyte they pass by facilitated or
passive diffusion into capillaries of the portal circulation.
3.5.5 Digestion and absorplion of prolcins The final products of protein digestion
are small peptides and free amino acids which are transported across the lipid
membrane by specific carrier mechanisms. Four different sodium-dependent systems
have been described, specific for the transport of neutral, dibasic and dicarboxylic
L-amino acids, and the imino acids (proline and hydroxyprolinc) and glycinc.
CytosoJic enzymes degrade the di- and tripeptides to amino acids, which Call diffuse
passively across the basolateral membrane into the portal blood.
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3.5.6 Absorplion of vitamins Waler-soluble vitamins are absorbed in the
jejunum and ileum, by diffusion which may be facilitated or active. Fat-soluble
vitamins are primarily absorbed in the proximal small intestine by solubilization
with fats in bile salt micelles.
3.5.7 Bile Bile is an alkaline aqueous solution of bile acids which is secreted into
the duodenum. Electrolyte concentrations are similar 10 those in plasma, with the
exception thai bicarbonate whose concentration in bile may be double that in plasma.
Other constituents of bile are phospholipids, cholesterol and small amounts of plasma
proteins. Bile may also contain lipids, steroid hormones, end-products of metabolism
of drugs and other foreign compounds, and traces of heavy metals such as lead.
Conjugated with glycine or taurine, bile acids are ionized althe pH of bile and
exist as salts of cations, e.g. Na taurocholate. The bile acid pool (about 3 g in
adult humans) circulates two or three times pcr meal and up to twelve times each day,
in an cnterohepatic circulation. Bile salts are actively reabsorbed in the ileum and
carried back to the liver in the portal circulation. The yellow colour of bile is due
to bilirubin, a breakdown product of haemoglobin, which is conjugated in the liver
wilh glucuronide and to a lesser extent with sulfate.
3.5.8 The gnll bladder In the rat and the whale, bile dmins directly into the
duodenum, but in mosl species, including humans, about half of the bile formed
in the liver is stored in the gall bladder. Here water and some bicarbonate and
chloride are resorbed, and so Ihe pH of gall bladder bile is lower and the
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bile salt concentration is higher than that of bile fresh from the liver.
Other constituents of bile, including drugs and other foreign compounds arc also
concentrated in the gall bladder, so that when gall bladder conlents arc ejected into
the duodenum in response to a meal, a bolus of highly concentrated chemicals is
delivered. By contrast, in animals which do not have a gall bladder, delivery ufbilc
and any other compounds it contains is a smoother process.
3.5.9 Digeslioll and absorption of fnls Triglyceride digestiull is initialed hy
preduooenal lipase; human gastric lipase (HGL) has a pH optimum of - 4.5 - 5.5
[lOS]. Bile salts activate HGL;/I vitro and it is possible that prcOtlodcnal lipascs
continue to act in the duodenum {l06J. in cooperation with pancrc<llic lipase
[1D7]. Peristaltic action in the small intestine promotes clllulsiliclltion of fats; this
is assisted by the presence of monoglycerides, fatty acids, lecithin and protein, and
is much more efficient in the duodenum than it is in the stomach. EllIulsitication
provides a large surface area for the action of pancreatic lipase, which can only
operate at the oil/water interface. Pure pancreatic lipase is inhibited by bile salts
(108], and in order to be active it requires the presence of colipasc 11091,
a small protein which anchors pancreatic lipase to the oil/water interface [IIOj.
III vitro, the pH optimum of pancreatic lipase alone is close to 8.0, but in the
presence of bile salts and colipase there is a downward shi ft to more acid values
(6.0 - 6,5) (Ill]. Hydrolysis of lriglyceridcs at positions I and 3 by pancreatic
lipase yields diglycerides and then the 2-monoglyceride and two fatly acids.
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These products of lipolysis are removed from lhe interface by solubilization
in bile salt micelles (see below), allowing the reaction to continue.
:1.5.10 Micelles and micellar solubilization of lipids Bile acid molecules are
amphipathic: their hydroxyl groups are arranged on one side of the molecule, and the
water-insoluble part faces the other way. Above the critical micellar concentration
(which varies from - 0.7 mM {I 12) to - 12 mM (113] according to the
properties of individual bile salts, the ionic composition of the medium, the
temperature, pH, and the presence or absence of lipids) bile acids in aqueous solution
lend to aggregate to form micelles. The hydrophilic aspect of each molecule faces
outward to the aqueous medium, and the nonpolar aspect faces inward. The
hydrophobic centre provides a milieu where lipid-soluble compounds such as
cholesterol can be carried. Simple micelles containing only bile salts are found in
vi/ro, but in vivo phospholipids and cholesterol from bile are incorporated, fanning
mixed micelles, Figure 3.6. Also incorpornted into mixed micelles are the products
of digeslK>n of dietary fats, and lipid-soluble compouocls. In addition to mixed
micelles, there may also be other lipid aggregates in the aqueous phase, whose
strur.turc will change during the course of absorption and digestion, depending on
the relative concentrations of mixed lipids and bile salts [114].
3.5.11 Ban'lers 10 the nbsorption of digestive products 111ere are three barriers
that digcstion products in the slllall intestine must cross before they pass into the
enlerocyte. The first is the unstirred water layer which exists close 10 the absorptive
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Figure 3.6 The sh'uclul'C or II llIb:cd micelle
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surface; the second is the mucus coal covering !he brush border; and the IhifTJ
is the lipid membrane and glycocalyx. The first two barriers present linle difficulty
to water-soluble comJX)Unds. Micellar solubilization enhances solubility of lipids
and lipid-soluble compounds in the aqueous phase by a faclor of about l()l, enabling
them 10 cross the unstirred water layer. This layer is thought to be between
100· 200 Jlrn thick in highly stirred systems ill vitro, and as much as 400 - 800 pm
in the intestine perfused in I'ivo [115J; confusion has arisen because some authors
have referred \0 "functional thickness· of the unstirred waler layer when it seems
they were including the layer of mucus overlying the brush border [116]. Mucus
is composed of mucopolysaccharide which acts as an ampholyte. It possesses many
ionizable groups of differcm pK, values and is therefore able 10 maintain the acidic
microclimate of the mucosal membrane in spite of the luminal pH, from which it may
differ by > 1.5 pH units. In the jejunum, e.g., the luminal pH is 6.8·7.2, while
thai of the mucosal surface is about 5.4 [117]. The lower pH close to the mucosal
membrane enhances both the diffusion of micelles and their dissociation, so that
micellar contents carried across the water and mucus layers are then released in
monomeric fonn, adjacent to the absorptive surface [118]. Short- and medium-
chain fatty acids and lheir triglycerides arc sufficiently soluble in the aqueous phase
that they cnn diffuse across the unstirrcd layer wilhout being associated with micelles,
but for the long-chain fally acids which make up 90% of ingested triglycerides,
micellar solubilizatjem is essential. The third barrier to digestive products, the
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mucosal membrane, is a phospholipid bilayer with a high protein to lipid r.dio
(= 1.7: I). Some of ils many proteins arc enzymes; others nelliS specific carriers
for the products of carbohydrate and protein digestion. Lipid and lipid-soluble
molecules move through the membrane by passive diffusion. In comparison with
many olhe',· biological membranes, the mucosal membr.lnc is less nuid [119].
3.5.12 Water and electrolyte absorption Water transport ill the intestine occurs
passively. It varies according to the region, depending on Ihe blood-lumen osmotic
pressure difference and on solute transport. Sodium is conserved very effectively
throughout the intestine by a numlK:T of mechanisms. Potassium is absorbed mainly
in the jejunum, chloride in the jejunum and ileum. Bicarbonatc is secrelcd into the
duodenum; in the jejunum, it is rdpidly reabsorbed whitt: H+ ions arc secreted, giving
rise 10 the acid microclimate close to the jejunal mllcosa. In the ilcllm, bicarbomltc is
secreted in exchange for chloride ions. Calcium is absorbed in Ihc duodenum and
jejunum; magnesium is absorbed througholltthe small intestine, mosily proximally.
About 90% of the nuid which enters the human large intestine is absorbed. Sodium
and chloride arc conserved, while bicarbonate and usually potassium arc secreted.
3.6 Pre-systemic metabolism: Phase I and P:IUSC II reactions [1201 Thc liver
is Ihe major site of xcnobiotic biotransformation but biotransformation also occurs
to a significant extent in the mucosal tissue of the gastrointcstinal tmct.
Biotransformations are c1assificd as phase I or phase II reactions. Phase I reactions
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generally alter the molecular structure of compounds by cytochrome P45G-mcdialed
oxidation or hydrolysis, whereas phase II reactions involve conjugation with groups
such as glucurooide, sulfate and glutathione. Many fat-soluble compounds are to
some eJ:tcnt resistant 10 biolransfotmatio... Metabolized compounds are usually
transported in the portal vein to the liver where further biotransformation can take
place, but a proportion may be exported directly from the intestinal tissue into the
gut lumen. The metabolites formed are generally more water-soluble than the parent
compounds; they bind less easily to plasma and tissue proteins, and are usually found
in lower concentrations in body storage depots. Biotransformation usually results in
metabolites which are less toxic than the parent compound. but occasionally more
toxic compounds are formed. Increased aqueous solubility facilitates excretion in bile
or urine; compounds excreted in bile may then be subjcctlO enlerohcpatic circulation.
3.6.1 Modification or intestinal biotransronnalion Many dietary components can
alter the extent of biolransformatioo: iOOoles present in brussel sprouts and excess
cholesterol have been shown to increase the activity of enzymes of oxKlation and
conjugalion; high intake of unsaturated fats decreases the activity of enzymes of
biotransformalion, as does deficiency of selenium or cholesterol.
OIucuronosyl-lransferasc activity can be induced by oral administration of
inducing agents sllch as phenobarbital or 3-methylcholanthrene.
3.6.2 Gastroinlestinal nora [121] Both anatomically and functionally, the waJl
of lhe gastrointestinal tracl is part of an animal's external surface. No part of the gut
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is normally sterile. Acidity keeps the stomach nearly ffl'C of bacteria, hut the
intestine contains large numbers of microbial organisms of which 95% arc strictly
anaerobic. Bacterial counts in the human intestine range frolll 101 • lO'/mL in the
proximal small intestine to JOll/mL in lhe ileum And colon. There h 1I.~ually a
balance between the various bacterial species, but this can be upset, I·.~. by.mliLliolic
therapy, which can cause serious side effects. Foreign compounds arc lllclOlbo1izcd
both by body tissues and by gut flora. Cytochrome P450-mcdimcd oxidation rcacli(}l1~
require oxygen, but mosl intestinal bacteria arc anaerobic. Mammalian bia-
transformations are generally oxidation and conjugation reactions. whcrcus reactions
carried out by intestinal bacteria are mainly reductions ami hydroly.'iC~.
3.7 Intracellular processing of lipid digestion producls: eslcl'iliclll illn of flilly
acids Within the enterocyte, long ehain fatty acids are re-esterified into
triglycerides, A fatty acid-binding protein (FABP) [122] which preferentially
binds long~ehain unsaturated fatly acids plays a major role in transporting fatty acids
to the endoplasmic reticulum where re-csterification takes place [123], It is
probable that binding to FABP is necessary for re-esterificalion_ Medium-chain falLy
acids (smaller than 12 carbons) do not bind with FABP which might explain why they
are largely absorbed in the unestcrified form viu the portnl system [1241. Two
metabolic pathways arc involved in the synthesis of triglycerides in the cn'craeyte,
the monoglyceride pathway and the ~·glycerophosphate pathway, The rnonoglyccride
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roule is the major pathway: activated fatty acids are added to monoglyceride in the
smooth endoplasmic reticulum, in reactions catalyzed by acyl CoA acyltransferases.
The glycerophosphate pathway, which is associated with the TOugh endoplasmic
reticulum, normally plays a minor role in triglyceride handling, probably because in
energy terms the monoglyceride pathway is more efficient, requiring four high energy
phosphate bonds rather than the len needed by the glycerophosphate pathway
(1241. Based on studies using intestinal microsomes and intestinal slices, some
3ulho,.s have proposed that the first reaction in the glycerophosphate pathway
conversion of glycerol 3-phosphalc 10 phosphatidic acid, is inhibited by high levels
of monoglyceride (I25]. Studies \Ising everted sacs of rat intestinal mucosa do not
support this theory (126), During fasting, when monoglyceride is not present in
the gut lumen, the glycerophosphate pathway becomes more important endogenous
fatly acids, and glycerol 3-phosphate derived from intracellular glucose metabolism
are used to synthesize glycerophospholipids. During fat absorption, triglyceride
droplets, often containing esterified cholesterol, accumulate within the smooth
endoplasmic reticulum. The particles receive a coating of apoprotein, cholesterol and
phospholipid in the rough endoplasmic reticulum and move to the Golgi apparatus
where carbohydrate moieties arc added. Packaged vesicles, the lipoprotein particles
lire delivered to the lateral cell membrane and released into the intercellular space.
They then pass through the basement membrane, across the lamina propria and into
the central lacteal through gaps in the endothelial lining of the lymph vessel.
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3.8 Lipoprotein particles [127] Lipoproteins aTC complexes of lipid and protein
which transport lipids in the circulation. They are classified according to density.
which is inversely related to lipid content. Table 3.1 shows the principal lipoproteins
and their composition [128J, Chylomicrons are synthesized in the iJllcslinc and
carry dietary triglyceride. Very low density lipoproteins (VLDL), which aTC
synthesized in both liver and intestine, are the major lipoprotein found during fasting;
this suggests that the lipid Ihey contain is largely derivt;d from endogenolls sources.
Low density lipoproteins (LOLl arc derived from VLDL and uclivcr cholesterol 10
the tissues. High density lipoproteins (HDL) arc synthesized in a disc-like fOfm in
the liver and small intestine; they scavenge excess cholesterol from chylomicron
remnants and VLDL. The inner hydrophobic core of lipoprotcins contains
triglyceride and cholesterol ester plus a little unesterified cholesterol; the surface is
made up of a phospholipid monolayer with small amounts of free cholesterol and
apoproteins. Apoproteins playa crucial role in lipoprotein transport and metabolism:
some are recognized by ligands and thus target thc lipoproteins to spt...'Cilic sites;
others bind and activate specific enzymes, e.g. LeAT <lecithin-cholesterol acyl-
transferase) is activated by apo A-I. Apoprotein B is necessary for the export of
ehylomicrons from the cell: in abetalipoproteincmia (the absence of apoprotein B)
lipid particles accumulate within the enterocyte and chylomicrons do not ilppcar in
lymph.
Table3.l
Composidon of the principle lipoprotein particles
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Chylomicru VLDL WL HDL
Dl,:nsity 0.95-1.006 1.006·1.063 1.063 - 1.210
Chcmic.ll
cmnposilion %
Triacylglyccrol 85 50 10
FrccchulcSlcml 1 1 8
Cholesterol CSlcr 12 J1 15
Phuspholipid 18 2. 24
Prtltcin 10 23 55
A.\lapted fmm Kritchevsky.D. 11181
3.9 Lymph composition and now Lymph contains all of the pmlcins found
in plasma, gellcmlly ill lower concentrations. In the dog, the gastric lymph: plasma
ratio for total protein was found to be 0.51. Specialized transport proteins such as
ferritin are also seen in lymph. Among 1I0n·prote1n constituents arc low molecular
weight substances « 10,(00) such as glucose. which arc found ill similar
concentrations in lymph and plasma. Substances which arc protein-bound in plasma
are found in lymph in concentrations determined by the relative concentmtions of the
binding proteins in plasma and lymph. Foreign substances transported in lymph
include toxins and bacteria. Toxins of high molecular weight arc selectively carried
in lymph, but lower molecular weight toxins arc tr.losported in hoth blood and lymph.
The composition of lymph is modified as nuid filters out and as the different
lymphatic branches empty into the main trunk. Passage through lymph nodes allows
some exchange of small molecules between blood and lymph, as well as the addition
of lymphocytes to lymph. The rate of formation of lymph is determined by the
amount of interstitial nuid which forms; this is a function of blood capillary
permeability and perfusion pressure. Intestinal lymph now is strongly innuenced hy
digestion and absorption. Contraction of gut musculature propels lymph onwards in
the central lactcals; contraction of smooth muscle fibrc.~ ill the walls of 1111.'tlium and
large lymph vessel move the lymph on towards the thoracic duct and su \0 the
systemic blood circulation. Variation of thoracic pressure with respiration alsu
promotes lymph flow. Valves in the lymph vessels prcventthc back nux of lymph.
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3.10 Transport fnull the gut After absorption into enterocytes (the absorptive cells
of the intestinal epithelium) compounds are transported from the gut either viti the
portal venous system, or if they are lipid-soluble, via the lymphatics. Some
compounds partition between the two routes. The portal vein carries compounds
to the liver where many arc extensively metabolized before being excreted in bile
or exported into the systemic circulation. This "firs(-passM hepatic metabolism of
compounds reduces the percentage of unchanged parent compound reaching the
general circulation. By contrast, because the lymphatic system drains into the
jugular vein, compounds carried in lymph bypass the liver and arc therefore not
subjccted \0 first-pass metabolism. These fat-soluble compounds are less easily
excreted and lend to accumulate in body stores.
4. RATIONALE AND OBJECTIVES OF TillS STUDY
In many studies of OTA absorption, OTA was administered in sodium
bicarbonate (129,130,131,132,133] but under natural conditions ingeslion of OTA
commonly occurs in the presence of lipids. Livestock cOllllllonly ingest OTA in
mOUldy cereals such as corn and barley and therefore OTA is accompanied by
plant fibre and a small percentage of ccreal oils, of the order of 3% [[341.
Human ingestion of OTA may occur with consumption of contaminatcd lllcal
or meat products, often with a high fat content, bread or other cereal products,
beans, or even human milk. Experimental studies of the toxic effects or OTA
have occasionally involved administration of the toxin supplemented hy, or
dissolved in, corn oil [135,136], but details of absorption were no\ discllssed.
The pUl'j)Ose or this study was to compare the erfect of the vehicle
• sodium bicarbonate or com oil • on the absorption of OTA,
and to investigate the effect of changing pH on the ioni7.ation stale
of OTA and its partition between aqueous and organic media.
5. MATERIALS AND METHODS
5.1 Chemicals OTA was isolated and purified as described by Omar (137).
It was shown to be 98~ pure on HPLC, using a Partisil 10 ODS column
(0.46 em x 2Scm) and a solvent system consisting of a 65:35 mixture of
(a) acetonitriJe:methanol, 1:1 vlv, and (b) 5 mM sodium acetate:acetic acid,
500:14 v/v. rH10TA} purchased from Amersham U.K. was purified by TLC,
using bcnzcne:mcthanol:acetic acid, 90:5:5 vIvas running solvent, then eluting
the OTA with benzene: acetic acid, 4:1 v/v. (lH]OTA was added to unlabelled OTA
..n<.l dissolved in 50 mM sodiulll bicarbonate or in com oil to give a concentration
of ISO p,glmL, 25 IlCi/rnL. Chemicals and solvents used were of the purest grade
available. Mawla com oil (Best Foods canada Inc), for culinary use, was purchased
locally and stored in the dark at 4 8 C. To dissolve OTA in com oil, it was first
dissolvec:l in a small volume of chloJroforrn which was added 10 com oil and
thoroughly vortexcd. The chloroform was removed by evaporation under vacuum for
allcast 4 hOUTS. In one set of experiments, [l·qtrilinolein } purchased from Dupont,
Boston MA U.S.A., was added to the com oil, 2:3 vlv, to give 2.0 p.Ci/mL.
5.2 Surgical supplies Xylazinc was purchased from Haver, Bayvet Division,
ChclI1agro Ltd., Etobicokc. Ontario. Kelaminc was purchased from MTC
Pharmaceuticals, Cambridge, Ontario. Clay Adams 7401 PE 10 and 50 polyethylene
J For rocalion of PHI and P~Cllabels, please see Appendix. pp. 153, 154.
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tubing was used for cannulation of the bile duct and intestinal lymph vessel.
A size 5 French infant nasogastric tube was lIsed as lhe gastric or duodenal cannula.
5.3 Surgery Male Sprague-Dawley rats (270 - 300 g) purchased from Charles
River, Canada Ltd. were anaesthetized by intramuscular injection of a mixture of
ketamine (40 mg/kg) and xylazine (5 mg/kg lip to weight 300 g. and above tlln'
weight, up to 6 mg/kg). After midline laparotomy, the duodenal loop was rcncclctl
to one side to expose the bile duct, which was cannulated proximal to the pancreas.
The main intestinal lymph vessel was cannulated where it runs alongside the superior
mesenteric artery, as described bJ Bollman t!/ al. (138). Figure 5.1. A c<ll\llul"
was inserted inlo either the stomach or duodenum, for administration of 5%
glucose/saline and the single dose of OTh. Tubing was hrought to the exterior
through individual stab wounds, and the incision was closed in two layers. In one
set of experiments, the bile duct was not cannulated; only lymph was collected.
After surgery, rats were restrained in Bollman cages and receiyed 5%
glucose/saline at a rate adequate to ensure good hydration, initially 2.3 • 2.4
mUhour. During a post surgery recovery period of 16·24 hours, bile was
collected from all animals witb a bile dUCI cannula.
5.4 Bile duct cannulation Cannulation of the bile duct diverts all the bile which in
natural circumslances nows into the duodenum. Normal absorptiun of mediulll and
long chain fatty acids depends on the presence of bile, so in order to promote normal
absorption, it is necessary to replace the bile diverted for coJJection. In most of Lhe
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Mesentery
Jo'igure 5.1
Dlngl'lllll to show cllllllulation of the bile ducl lllld main lntestim:'l >,Vmph vessel
AJa]lII.'tI frnmLmlhl:rt 11391
experiments in which the bile duct was cannulated, bile collccted dllfing the
post-surgical recovery period was mixed with glucose/saline (I rnL bile: = 5 IllL
glucose/saline) and rein fused at 3.1 mUhollT I'ill the gastric or duodenal call1lula,
starting about one hour before the dose of OTA was given. The proportion of
bile: glucose/saline was calculated so that at the now rate chosen to give adcquatc
hydration, sufficient bile was reinfused to replace losses, due to bile diversion,
over the time course of the experiment. Ideally, rcinfuscd l>ilc should in 0111 cases
have been delivered to the duodenum. but in lhe experiments in which OTA was
administered intragastrically, bile was infused illlo the stomach. It is prohable thill
at the pH prevailing in the stomach, mechanisms of OTA absorption would not be
significantly affected by the presence of bile.
5.5 III vivo experiments 4 A summary of i/1 vivo experiments is given in Table 5.1.
eHJOTA was given in a single bolus dose, usually 288.8 pg/kg, 40 pCurics/kg
(in one instance, double the dose was used) in cithcr 50 mM sodium bicarbonate
or corn oil (1.67 mUkg) via the gastric or duodenal cannula, (or in intact anim,\ls
by oral gavage). This dose approximated two days' intake of OTA of rat chow
contaminated by 4 ppm OTA [140}. This is similar to concentrations sometimes
found in naturally contaminate<i livestock feed [251. In onc clIpcrimclll, a dosc of
• Experiments were performed umler the !:uidclinc.~ and with the approval of the ,'nim!l!
Care Committee of Memorial University of Newfuundland.
Table S.l Summary or ill vivo experiments
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3 mg eH}OTi\lkg body weight was gillen orally to intact rats. After the test dose
was given, hydration was resumed, operated animals receiving glucose/saline ± bile
viu the cannula, and orally-dosed rats haYing waler ad IiI),
5.5.1 In the first experiment, the bile duct was cannulated, and bile and urine
were collected over icc, protected from light, for twelve hours after intraduodenal
administration of [lH]OTA in sodium bicarbonate, to observe the appearance of [JH]
label in bile and urine and to determine an appropriate lime frame for subsequent
experiments. In order to identify those organs in which OTA was deposited, organs
were CJiciscd. blotted and weighed, and weighed samples of liver, kidney, lungs,
pancreas, splccn and epididymal fat, and also intestinal contents and feces, were
solubi1il.l,.'d in NCS tissue solubilizer (Amersharn. Canada Ltd., Oakville, Ontario)
and when dissolved, duplicate 80 poL aliquots were taken and neulralized with
glacial acetic acid before counting of radiolabel.
5.5.2 In cxperiment (2). liver and kidney samples were taken from four groups of
rats, six, twclvc, cighteen and twenty-four hours after intraduodenal dosing with
["'Hl0TA in sodium bicarbonate. The bile duct was cannulated in the usual manner
and the polyethylene tubing was brought through the stab wound to the exterior but
thcn looped back into the abdominal cavity to drain into the duodenum, so that
initially bilc was 1101 collected. For the last six hours of the experiment, the
cxteriorized loop of tubing was cut so that bile could be collected, e.g. in the six hour
cxperiment, bile was collected immediately after the dose of OTA was given, ulltil the
rats were sacrificed at six hours posl dosing; in the twenty-four hour 1l.'llI:rimllnt,
bile collection starled at eighteen hours.
5.5.3 In experiment (3), [JH]OTA was administered intmgastrically in either
bicarbonate or com oil, to see if the vehir.lc used affected thll rolltll of absorption.
5.5.4 This experiment involved intragastric administration of phenylalaninll wilh
OTA in bicarbonate (in a molar ratio. phenylalanine: OTA, approximately 10: I,
i.e. 4: I by weight). 10 see if simullaneous administmtion of phcnylalill1inc cither
enhanced gastric absorption or OTA. as suggested by some authors [130\,
or reduced ii, as proposed by others [141].
5.5.5 In experiment (5), [JH10TA was administered to t1m.'C groups Ilf rats
inlraduodenally, to eliminate any differences resulting frum vari;,hle timillg (If
gastric emptying. These rats were designatcd group IJ+ (thuse rats givcn OT/\
in bicarbonate, with bile reinfused), group C+ (those rats given OTA in corn oil,
with hile rein fused) and group C- (OTA in corn oil, without rein fused hi Ie).
5.5.6 In a subsequent experiment, the intestinal lymph vc.~scl w~'s cannulated but
not the bile duct; additional bile was not rcinfuscd. rlH10TA was administered
intraduodenally in a single dosc, 288.8 ~g/kg, 40 ~Ci/kg, in [14C)eorn oil
(1.67 mUkg, 3.33 ~Ci/kg). It was then pos.~ihlc to rollow concurrently the
absorption and transport of ['4C]lipid and [lH]OTA. Intestinal tissues <lnd contents
were extracted, in order to ascertain how much of the dose remained in the digestive
tract when each animal was sacrificed, six hours after dosing. Duplicatc aliquots of
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lymph collected in this experiment were taken for counting of radioactive labels,
then the lymph collected from each rat over the first two hours and the fourth and
firth hours was centrifuged as described in 5.6.2, to separate chylomicra and VLDL
from infranatant.
5.5.7 In experiment (7), intact rats were given rH]OTA, 288.8 p.g/kg, in bicarbonate
or corn oil 1.67 mUkg in a single dose, by oral gavage. Four of the bicarbonale-
dosed rats were pre-treated for five days with phenobarbital, concentration 0.1 % in
drinking water. Phenobarbital treatment induces the cytochrome P450 enzymes which
are responsible for hydroxylation ofQTA to 4-hydroxyochratoxin A (4-0H-OTA).
One set of rats had free access 10 chow and water before and after dosing wilh OTA.
Other rats were fasted for either eighteen or twenty·four hours prior to dosing, and
for thc six or twenty-four hours after dosing. All rats had water af/lib. throughout.
Six or Iwenty·four hours after receiving OTA, rats were sacrificed. Blood was taken
from the abdominal aorta; weighed liver and kidney samples, and gut tissues and
contents were taken for extraction of OTA as described under 5.6.4.
5.5.8 In experiment (8), intact rats were given [lH]OTA 3.0 mg/kg in bicarbonate,
by oral gavage. After dosing, urine was collected for six days, to observe the
clearance of OTA in urine. Duplicate atiquots were taken for counting of [lH] labet,
and the remainder of each collection was extracted immediately in chloroform as
described in 5.6.4, or frozen al· 2QoC for extraction laler.
5.6 Sample Collections Pre-dose collections of urine. bile and/or lymph. and in
one experiment, blood, were made. After OTA administralion. bile and/or lymph
were collected on ice, every IS minutes for the tirst 2 hours. and at 'h thcn 1 hom
intervals thereafter, for 6 or 7 hours. [n thc experiment in which ~crum levcls of
OTA were measured, 6 drops of blood. total volume approximately 150 • 200 Ill.
were collected from a femoral arterial line at each lime point. Urine WlIS collectc<1 OlS
it was produced. When all bile and lymph collections had been complcted. rolts wcre
anaesthetized as described previously, the abdominal cavity was opened by midline
incision and a sample of blood was obtained by left ventricular punchlTc or fmm thc
abdominal aorta. Blood was allowed to stano at room tcmperature for at least one
hour, then centrifuged for to minutes at 250 g to give serum as the sUIx:nml'llIl.
5.6.1 Counting of radioactive label [lHJ and in one cxperimcnt p.ICJ were counted
in order to follow [3HJOTA and ['~C]trilinolein. Scintillation fluid (Scintivcrsc II.
Fisher Scientific) was added to duplicate aliquots of bile, lymph, urinc, serum ;Inu
solubilized or extracted gut contents and tissue samples. Where tissuc soillhitizcr IH,d
been used, glacial acetic acid was added to solubilized tissue, I PoL acid 10 I() pL
sample, to neutralize the alkalinc solution. Aftcr cooling overnight in the dark,
sample aliquots were counted in a Beckman LS ISOI scintillation counter.
5.6.2 Centrifugation of lymph Fresh lymph, from experimcnt (6) in which rats
were given eHjOTA in [14CJcorn oil, was overlaid with 1.006 gIL <lcnsity solution \
S For preparation Ill' 1.006 glmL densily slllutiun, see Appendix, p. 154.
65
and centrifuged for 40 minutes at 177,700 g (7.1 x 1(1i) at room temperature in
a Beckman L5 50B ultracentrifuge, to separate chylomicra. After slicing the tube,
lhe chylomicra were withdrawn by pipette. The remaining solution was transferred
by pipette to another centrifuge tube, overlaid with 1.006 gIL density solution,
and centrifuged again at 177,700 g for 18 hours (1.9 x let) to separate VLDL
from infranatant. Duplicate aliquois of chylomicrons, VLDL and the infranatant
were taken for oounting of [lHj and [14C].
5.6.3 EsIimnlioll of gilt contents and tissues Gut contents from two rats dosed
wilh fHJOTA in (1~C]corn oi] were collected in order to assess how much of the
c.losc had been absorbed during the course of the experiment. The stomach was tied
off from the oesophagus at the level of the diaphragm, and from the small intestine,
close to the pylorus, The intestine was separated from mesentery and tied off
distally at the i1eocaecal junction. The caecum and oolon were excised in one piece.
After excision, the small intestine was divided by ligatures and cut into four segments
of equal h:ngth. Each gut segment was rinsed carefully three limes with 0.5% sodium
taurocholate in normal saline; from the washings 500 p.L was taken for counting of
fH] and [1.1C] label. When gut tissues and contents from intact rats were extracted,
gut segments were excised and divided as described, but were rinsed only twice with
0.5% sodium taurocholate in normal saline, then twice with 50 mM bicarborate.
Gut contents and rinsings were then extracted as described in 5.6.4. Tissues were
chopped finely then acidified and homogenized in a Waring blender before extraction.
5.6.4 Extraction orOTA Samples were brought 10 pH 2.0 by addition of Hel.
then extracted three times in chloroform. Duplicate aliquOls (If aqucous extracts were
taken for counting of [lHJ label; chloroform c:<tracts were dried under nitrogen ,lIld
dissolved in methanol, then aliquots were taken for counting of {-'Hjlabel. Aqueous
extracts were freeze dried then dissolved in methanol or lllcthanol:watcr, 80:20.
5.6.5 HPI.£ analysis The chloroform and aqueous extraeh were liltcrcd through
a 0.45 pm HPLC filter prior to analysis by HPLC. A Perkin Elmer ISS HXl
autosampler and an LS-5 fluorescence spectrophotometer were llsed with a ~ltl>clcIlSil
LC 18 column, 3.3 em x 4.6 mm x 3.0 ~M. TI1C solvent system uscd was
methanol:water, 80:20 or 64:36, with a flow rate of I mUmil1utc. Samples were
detected by fluorimeter, with excitation set at 340 nm and emission at 465 1111l.
HPLC was used to clarify whether OTA was prescnt in extracted s;unplcs in Ihe
parent form or as a metabolite.
5.7 In vitro experiments
5.7,1 Partition between organic and aqueous media Partition of [lH]OT/\ between
chloroform and phosphate buffer, and between cOIn oil and phosphate buffer, W<lS
studied at a range of pH from 2.5 to 8.5 by comparing {lH] labcl and by ob.'~crvjng
fluorescence under ultraviolet light in the two phases. In the chloroform/phosphale
buffcr experimcnt, [lH]OTA was dissolved in potassium phosphate buffer (0.1 M) to
give a final concentration 13.3 /-1M (0.125 ~Ci/mL) and I: I mixtures of chloroform
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and OTA in buffer (2 mL total) were vortcxcd prior to centrifugation at 1000 g
for len minutes. In the corn oil/phosphate buffer experiment, OTA was dissolved
in corn oil to give a final concentration 13.3 J.tM (0.05 IlCilmL). I: I mixtures of
buffer and OTA in corn oil (2 mL total) were vortexed, then onc of each duplicate
was shaken, and the other rotated at 22 rpm, at room temperature for 19 hours,
protected from light, prior to centrifugation and separation of phases.
5.7.2 Absorbance scan at different pH Protonation of the phenolic group at C~
was investigated by scanning between 300 and 400 om the absorbance of solutions
of OTA in phosphate buffer at a range of pH between 5.0 and 10.5, as described
by PiloUI (26].
S.7.3 Slnndnrd curves: known amounts of QTA and Oa were run on HPLC and
the peak areas were plOlled against mass in ng so that quantities ofOTA and Oa in
samples could be estimated. 4(R) and 4(8) 4-0H OTA were assumed to have the
same fluorescence coefficient as OTA.
5.8 Statis1ical analysis Data from rats whose lymph flow was less than 3 ml during
the first 2 hours after OTA administration were not included in the statistical analysis.
I" ,'iI'o data were analyzed by the Wilcoxon rank-sum tcst, taking an or value of 0.05
as significant.
6. RESULTS
6.1 In I'ivo studies
6.1.1 The aim of the first experiment was to demonstrate in gcnerul terms the
absorption, disposition and excretion of OTA, and to determinc an <lppropriatc
time frame for subsequent experiments. [JH10TA in 50 mM sodium hicmbonatc
was given intraduodenally to two rats. one receiving 288.8 JAg/kg body wdght.
and the second double that dose, 577.6 JAg/kg. Bile and urinc were collectcd over
the course of the experiment, and when the animals were killed twelve hours ancr
dosing, organ samples and intestinal contents and feces were solubilil.cd. Duplicatc
aliquots of all samples were taken for counting of [lH] label. Table 6.1 shows the
twelve hour recovery of [lH] label from the two rats, expressed as <I percentage or
dose administered. Percentage recovery was similar in the two animals. except that
recovery in urine. intestinal contents and liver was higher in the rat given the
larger dose. Only - 30% of the administered dose was recovercd: it is probable
that a further 10% may have been in the serum, and perhaps as much as 30% in
skin, muscle and intestinal tissues, which were not sampled. Only excrell..'<1 urine
was collected: urine in the bladder was not recovered.
From the profile of eHl appearance in bile (data not shown), it was seen th"t
if bile was collectcd, i.e. withdrawn from the system, so that enterotlcpatic circulation
of the toxin was prevented, 65% of the twelve hour total orOTA had already
appeared in six hours. Based on percentage recovery in the different organs, and
Tuhle 6.1
Twelve hour recovery of (lH] label from two rats
given fU]OTA intraduodellCllly in sodium bicarbOlmlc
Dose ['H]OTA 288.8 ~g/kg 577.6 ~g/kg
Bile 20.49 20.56
Urinc 5.80 8.(:')
Liver 2.20 3.15
Kidncys 0.48 0.50
Lungs 0.41 0.44
Pancreas 0.21 0.23
Spleen < 0.10 < 0.10
Epidydi1l1al fat ilIa 0.11
Intcstinal Cfmtcnls 0.60 1.57
Feces 0.06 0.05
LJH]OTA was administered intrnduodenal1y in 50 111M sodium
bicarbonate, 1.61 rnUkg. Recovery is expressed in terms of the
whole organ or collection. as a percentage of dose administered.
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literature repor15 of pathology caused by ingestion of OTA. it was dL"Ci<k."tI
that in future experiments. only liver and kidneys would be harvcst...'tI.
6.1.2 The second experiment was set up 10 observe how much ofll"IC m.lrninisICR.'(1
dose persisted in rat serum, liver and kidneys at 6, 12, 18 and 24 hours after
intraduodenal administration of OTA in bicarbonate. and to give an klea of how
much OTA was circulating in bile.
Figure 6.1 shows that recovery of eHllabcl in samples Occn.:a.'iCd with time:
twelve-hour samples had significantly lower percentage n..'covery of OTA than the
six-hour samples (p S 0.05 for serum, bile and liver, :lnd p = 0.01 for kidney);
eighteen-hour serum, bile and liver samples had significAntly lower levels in tcrms
of administered dose than the twelve-hour samples (p S 0.05). Although the tot,.1
recovery of eHlOTA from liver was greater than that rronl kidney. the rccovery/g
tissue was higher in the kidney at each time point, as shown in Table 6.2.
6.1.3 There has been some discussion as to lhe importance of the stomach in the
absorption of OTA: Kumagai and Aibara isolat~various 5Cgments or the gastru-
intestinal tract of the rat and demonstrated that the primary site or arA absorption
is the small intestine. with the most efficient absorption occurring in the jejunum
[128]; Galtier {l42] reported that gastric absorption played a major role. and I<oth
(working with mice) noted rapitl absorption ofOTA from the stomach [129J. Thc.~e
authors used OTA in sodium bicarbonate. We thererorc gave arA intragastrically to
two groups or rats, using sodium bicarbonate as the vehicle for the first group <Inti,
15·
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'2 ,. 24
Time (hr) after OTA administration
Figure 6. t Recovery of eHjOTA ill serum, bile, live.' and kidneys after
intraduodclIallidministratioll of [JH)OTA in sodium bicarbonate
OTA was administered a\ a dose of 288.8 JAg/kg. Overnight bile was reinfused.
Recovery is expressed as a percentage of dose administered.
Values shown are means d: SO. Calculation arDTA serum levels was made
on lile basis that serum volume is 0.55 blood volume, which in turn, expressed
in mL, is 0.07 mass of the rat expressed in g; thus total serum volume is taken
as 0.0385 mass of the ral. Bile was initially allowed to drain into the
duodenum. but for the last six hours of each experiment it was collected.
Levels in bile arc plotted to show OTA recovery during fhe six hour collection.
Table 6.2
Ret::overy or rHlOTA in liver and kidney
Tlme in hours Recovery of [JH} label, % dose/g tissue
Liver Kidney
6 (n =4) 0.18 ± .02 0.28 ± .05 ...
12 (n =4) 0.14 ± .03 0.16 ± .03
18 (n = 4) 0.09 ± .02 0.11 ± .05
24 (n =7) 0.11 ± .02 0.13 ± .03 •
[JH]OTA was administered at a dose of 288.8 ~g/kg.
in 50 mM sodium bicarbonate, 1.67 mUkg. Recovery
is expressed as percentage of administered dose, per g
wet (blotted) tissue. Values shown are means ± SO.
... • indicate significant differences p = 0.01, 0..05,
between liver and kidney in recovery of [lH}/g tissue
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recognizing that lipid is often present when OTA is ingested, corn oil for the second.
[lH] counls were secn in lymph, scrum and bile within 15 minutes, and reached peak
valuc.~ within I hour of OTA administration. Figure 6.2 shows the cumulative
recovery of [JH]OTA in lymph lind bile in these animals. From 15 minutes up \0 3
hours, significantly more OTA was recovered in bile when bicarbonate rather than
com oil was used as vehicle (p = 0.01 from 30 minutes to 1\4 hours after dosing,
and p =: 0.05 frum 1'A hours to 3 hours; thereafter, the difference was insignificant).
The results or this experiment are summarized in Table 6.3, which shows the
recovery of [lH] label in bile, lymph, serum and urine, expressed as a percentage of
dose administered, seven hours after dosing with [lH]OTA. Recovery in bile over
seven hours was more when the vehicle was bicarbonate, (16.7 ± 5.9%, n = 5),
than when corn oil was used (10.4 ± 2.7%, n = 3). Less [JH] label was recovered
in lymph when OTA was given in bicarbonate (10.6 ± 4.0%) rather than in com oil
(17.7 ± 5.2 %). These differences were not significant. In this experimental
system, in which lymph was collected from the main intestinal lymphatic vessel, it
was assumed that no OTA could reach the general circulation by the lymphatic route.
OTA appearing in bile must first have been absorbed via the portal vein, transported
to the liver and thence exported into bile (and serum). Recovery orOTA in bile
therefore gives an indication of portal venous uptake, whereas OTA recovery in
lymph is a direct measure of lymphatic transport.
• onlnWr... flo'
• on 10.........1
'--;~--r--.---,-._­
- ..
Joigure 6.2
CUllIulative l"C(oycry of 1311)labcl ill lymph lllld bile uf ral.~
givcn fHjOTA intragasiriclilly ill sodium bicarbmmte 01' ciln. nil
OTA was ad11linistereU at a dose of 288,8 p.g/kg, Overnight bile was
reinfused. Recovery is expressed as a percentage of dose administered.
Values shown are means ± SO, when: n(biearb) =< 5. n(oom oil) :::1 :\
(-) (.) dcnote significant differences. p = 0.01 and 0.05 respectively
between the two groups in recovcry of eH] label.
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Table 6.3
Seven hour recovery of [311] label after intragastric administrafion of [3H]OTA
OTAlNaHCOJ + bile OTAlcorn oil + bile
n = 5 n "" 3
Bile 16.7 ± 5.9 10.4 ± 2.7
Lymph 10.6 ± 4.0 17.7 ± 5.2
Senlm I 6.8, 6.' 8.1 ± 4.7
(n =2)
Urine 5.1 ± 0.8 2.0 ± 0.64 *
OTA was administered at a dose of 288.8 ILg/kg. Bile was rein fused. Recovery is
expressed as a percentage of dose administered. Values shown aTC means ± SD.
Key: (*) denotes a significant difference (p "" 0.01)
frollllhc group of rats given OTA in NaHCOJ•
I Serum OTA WIlS calculated by assuming that serum volume is 0.55 blood volume,
which in lurn, cxprcs~ in mL, is 0.07 mass of the ml, expressed in g.
Serum volume is thercfure 0.0385 mass of the rat.
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6.1.4 Roth et 01. (129) also reported that gastric :lbsorption in l\IiCl.~ was enhanced
by simullam..'Ous administration of phenylalanine, whereas lJclncruz and H~ICh 11:\~1
suggested that OTA may be transported into the abS(lrptivc cell hy Ihe Na' -dt:]lI:ndclll
carrier system specific to the L-iSOl11crs of nCUlral :Imino acids [1431.
With its L-phenylalanine group, OTA might well be recognized h~, this system.
We examined the effect of simultaneously administered phcnyJal,l1Iill1': on the
appearance of OTA in lymph and bile, to determine whether phcnylillaninc affectctl
OTA absorption. Table 6,4 shows the recovery of [-'H] label in bile and lyl11ph
when OTA in bicarbonate was given inLragaslrically with or wilhout phenylalanine.
Simultaneous inlragaslric administration of phenylalanine minimally dcprcs.<;cd
recovery of OTA in bile and had no effect on recovery in lymph.
6.1.5 Knowing that bile is important in fat absorption, we wondered if it plays allY
role in the absorption afOTA. We therefore compared the appcamncc (If 11HIOTI\
in lymph and bile when OTA in corn oil was administered either with rcplacemcnt
of bilc lost as a result of bile diversion (group C+), or withollt reillfuscd bile
(group C-). A third group of rals (group B+) received OTA in sodium bicarbonatc.
To eliminate differences due [0 variable timing of gastric emptyinl;, the dose Ill' OTA
was administered intraduodenally. Plots showing recovery/minute (Figure 6.:'1) and
cumulative recovery of label in lymph and bile (Figure 6.4) had typie:tl profile.~,
which varied according to the vehicle used. Bile now was consistcnt, whcrca.~
lymph flow was always variable (Figure 6.5).
Table 6.4
Seven hour recovery of [311] label in bile and lymph ltftt'T illtrngaslrk
admini.~lralionof PHlOTA in sodium bicarbonlltt' ± phl'Il)'l:thlllilU'
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Bile
Lymph
OTAfNaHC03 + Phe
+ bile
(n - 4)
19.4 ± 2.2
13.4 ± 1.2
OTAlNaHCOJ - Phe
+ bile
(n - 2)
22.0,22.9
14.2, 12.9
[JH]OTA was administered al a dose of 288.8 Ilg/kg. Phcnylahlllinc
was given concurrently at a dose of 1.155 mg/kg, i.e. 4-fold by weight,
lO·fold by molar concentration in comparison with OTA. Bile was
reinfused. Recovery is expressed as a percentage of OTA administered.
Values shown are means ± SD (n = 4) or individual values (n = 2).
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Figure 6.3 Recovery of (3H) label/minute in lymph and bile of two rats aller
illtraduodenal administration of eHJOTA in sodium bicarbonate or corn oil
(lH]OTA was administered in bicarLonate ('), or com oil (e), with overnight
bile reinfused, al a dose of 288.8 Pi/kg body weight. Recovery/minute in
(a) lymph and (b) bile is expressed as a percentage of dose administered.
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Figure 6.4
Cumulative recovery or rHJ label in lymph lind bile nfter illtr:lduodclIlll
administration or rH]OTA in sodium bicarbOllulc or corn oil
(lH]OTA was administered in NaHCO) (-) (8+), or corn oil (-) (C+),
with overnight bile reinrused, or in corn oil without rcinrusion of bile (',) (C-),
at a dose or 288.8 pglkg body weight.
Values shown are means ± SO, where n(8+) = 5, n(C+) c: 8 and n(C-) = 4.
(-) (.) denote significant differences, p < 0.01 lind S; 0.05 rCSflectivcly
between B+ and C+ in recovery of I'HIIllbel.
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Figure 6.5
Lymph and bilc flow in two rals after intraduodenal
administration of ['H)OTA in sodium bicarbonate or corn oil
rJH10TA was administered in NaHCO) (-), or com oil (e), with
overnighl bile reinfusod, al a dose of 288.8 Jtglkg body weight.
Lymph and bile now is expressed in mUminule
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Data reported in Figure 6.4 and Table 6.5 show that intmduodellOlt
administration of OTA in com oit (C+) enhanced uptake of OTA by the Iymphalic
route. Over the first llA hours there was no signilicMI difference between groups
B+ and C+; thereafter, significanl1y Illorc OTA was laken up in lymph in groUtl
C+, p :S 0.05. Administration in bicarbonate (B+) significantly incl'I.'ascd
cumulative recovery in bile, p < O.Ot, at atltimc points. Table 6.6 shows the
relationship between lymph now and OTA uptake in lymph. 11lcre was a signilic<lm
difference between groups B+ and C+ with respect to fH10TA uptake/mL of
lymph. In all three groups, lymph flow increased significantly from basal levels ill
response to administration of OTA; the increase was significantly greater in uihlll,~ed
rats than in bicarbonate-dosed animals (Table 6.7). Between groups C+ ilnd C-,
the increase in lymph now was not significant, but the C+ groul) had significilnl1y
greater lymphatic uptake of [lH}OTA than the bile-deficient C- group (p < a.05,
at all time points after the first 15 minutes); recovery of [JHI label in bile wa.~
essentially the same whether or not bile was reinfused. No chylomicrons were .'il,.'Cl1
unless both corn oil and bile were present. or the rats givcn bilc infusions, total
eHJ recovery over six hours was significantly less (p < 0.05) in the C+ group
(39.0 ± 9,7%) than in the B+ group (47.8 ± 5.1 %). Total recovery in the
C- group was much less (25.7 ± 6,67%), P = 0.01 by comparison with 11+,
and p < 0.05 when compared with C+.
Table 6.5
Six hour recovery of ell] label after
intraduodemd administration of fHlOTA
8+ c+ c-
(0""5) (n .= 8) (n = 4)
Bile 14.8 ± 2.5 '" 9.1 ± 2.7 8.0 ± 2.0
Lymph to.7 ± 3.6 * 19.8 ± 7.7 9.3 ± 3.1·
Serum 19.8 ± 1.3 '" 8.8 ± 3.2 4.5 ± 0.5 *'
(n = 3) (n = 7)
Urine 3.2 ± 0.7 3.4 ± 2.1 2.6 ± 1.5
(n = 4)
OTA was administered at a dose of288.8 fig/kg. Bile was reinfused.
Recovery is expressed as a percentage of dose administered.
Values shown are means ± SD. (ill) (.) denote a significant difference
(p :s; 0.01) (p < 0.05) from group C+. There is also a significant
difference (p = 0.01) in biliary recovery between groups 8+ and C-.
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Table 6.6
Lymph now and lymphatic uptake of rU]OTA
Time Group
"
Lymph now OTAuplllke Uplllkel now
(h,) (mLl (~dllSe) ('%dll:!ic/mL)
B+ 4.81 ± 1.46 6.93 ± 2.83 0 1.04 ± 0.62
0·' c+ 4.75 ± 1.07 12.66 ± 5,42 2.91 ± 1.60
B+ 14.9S ± 4.76 10.12 ± 3.63 0.79 ± 0.48
0·' c+ 15.42 ± 4.38 19.75 ± 7.68 1.39 ± 0.68
c- 5.63 ± 1.84 5.76 ± 2.11 1.10 ± 0.58
0-' c+ 4.75 ± 1.01 12.66 ± 5.42 2.91 ± 1.60
c- 17.51 ± 5.54 9.32 ± 3.09 0.58 ± 0.31
0-' c+ 15.42 ± 4.38 19.75 ± 7.68 1.39 ± 0.68
OTA was administered at a dose of 288.8 pg/kg. Bile was reinfused. Recovery
is expressed as a pereel'lage of dose. Values shown ate means ± SO.
(0) (.. ) denOie a significant difference (p =0.05) (p < 0.05) from group C+.
S.I
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Table 6.7 Increase in lymph now, and lymphatic uptake of Ochratoxin A
TIme V\!hidc Rei"ru~cd , Jncrt'lL~e In QTA
(br) hile lymph nllW: uptukt't
% ahove ba.~al in lymph
4.7 ± 2.' 3.46 ± 1.42
0-2
18.9 ± 9.0
0.01 6.33 ± 2.71
0.05
7.8 ± 6.5 1.19 ± 0.6
0-6
24.6 ± 11.3
0.01
3.30 ± 1.28
0.01
18.9 ± 9.0 6.33 ± 2.7l
0-2
20.7 ± 4.1 2.88 ± 1.06
< 0.05
24.6 ± 11.3 3.30 ± 1.28
0-6 25.S ± 8.0 1.56 ± 0.52 < 0.05
4.7 ± 2.1 3.46 ± 1.42
0-2
20.7 ± 4.1
0.01
2.88 ± 1.06
7.8 ± 6.5 1.80 ± 0.70
25.05 ± 8.0
< 0.05
1.56 ± 0.52
00113 given are for three groups of rOIls, B+ (bicarbonate + bile), C+ (corn oil + bile)
and C- (corn oil - bile), for the first two hours and for the six hours after OTA
administration. t OTA uptake is expressed as percentage of administered dose taken up
in lymph, per hour.
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6.1.6 In order to und~rstand more fUlly how the presence ("If lipids al"li:cts OTt\
absorption, we added 1'4qtrillnolein to corn oil, and Ihis was used as the vehicle
for IlH10TA. It was then possible to follow the appcarilllcll uf\l\llh 1;lbcls in IYlllph.
and after centrifugation, in chylomicra and very low density lipoproteins (VtllL),
Extraction of gut contents enabled us to ascl:rtain how milch OTA and Cl'rll oil r.:nmincd
in the digestive tract when animals were sacrificed six ]\(\urs ;lflllr dosing.
Figure 6.6 shows the cumulative appearance of IlHI :llltlll'ICjlllhd ill lymph
of five rats after inlraduodenall,IHtOTA adminislnltion in jlolcr ..:orn oil. I"HI label
was seen within fifteen minutes of dosing; most or the OTA transported in lymph was
recovered within the first two hours. By contrast, 1'4C1 uptake st:lrtcd slowly and
continued throughout the siK hour experimcnt. Figure 6.7 shows the pcrcentage
distribution of PH] and 1'·Cjlabel in chylomicrons, VLDL and infranatant aftcr
centrifugation of the lymph collected in the first two and the fourth and fifth hours after
OTA was given. These results show clearly that OTA in the lymph is nol carried in
chylomicrons or VLDL. Tabl,,) 6.8 shows thc recovery of I-'HI and 1'4C1 frolll intc.~linal
contents of two animals in this eKperiment. ApproKimately 30% of th(: dose administered
was recovered in luminal washings, mostly in the distal part of the small intcstine ;md the
cecum and colon. Recovery of IJHI label from the disla! parts of the gastrointestinaltr:lct
does not distinguish between OTA which has not been absorbed, and QTA which has
been absorbed and subsequently eKcreted in bile. On the other h:and, 1'4C1I:abcl found in
the lumen six hours after dosing mostly (because of dilution of absorbed lipid with the
endogenous lipid pool before excretion in bile) represcnts unabsorbed lipid.
2.10
T"ne(tnin)
l'igUrl' 6.6
Cumulative r('covery of [JHJ and [,~CJ label in lymph
(If rllls given LJHJOTA ill [uCJcurn oil intraduodeuully
[JH]OTA was administered (n = 5) at a dose of 288.8 ~g/kg
in 1'~C]corn oil, J .67 lIlUkg. Recovt:ry is expresSl.-'(] as a
percentage of dose administered.
(0) (.) denote significant differences in cumulative percentage
recovery of ["H] and (Ilq. p = 0.01 and 0.05 respectively.
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Figure 6.7 Pel'celltage distribution Qf (Jill lind rl~q 1;,hcJ
in chylomicr:I, VUH.. :lIId infr:umtant
I'H IOTA W"<IS at.Irninisterctltu the riw rJ\s d,;.~~rilJW in l'igurc 6.6, in
1'''Cleorn oil, 1.67 mllkg. Lymph Cl.IlI1".'l.1w UVo.:f Ihl: finot !WlIIWMJfS and
che fourth and nfrh hoon; Waf overlaid with 1.006 glmL I.h:n.~iIY sululilln,
I.:emrifuged at In.? I 10' g for 40 minutes to give chylumicra. lhen
overlaid with more 1.006 g1mL 1lOllllion. jntl centrifugw at 1n.7 I 1O~ g
for 18 hou~, ttl give VLDL anc..l infl1lniui&JIl.
Table 6.8
Recovery of [lH) and (14C) Inbcl from luminal contents of t\\'o I'als
six hours anel' illll~lduodcmlllldlJlillistl1llion oreliJOTA ill (I~CJcorn oil
Luminal Contents
(I'CJ
ShlllIadl 0,0,0.7 0.0. 0.1
Inlestinel 0.4.0.5 0.1, 0.1
Intcstincll 0.5.0.1 0.1. 0.2
lnlcslinclll 1.9,0.6 0.5. 0.2
Intestine IV 21.6,3.6 5.l!, 0.7
Cecuill + cnlnn 9.1,23.1 20.8.22.8
TUlltl Recovery 33.5.29.2 27.3,24.1
I'Hl0TA was :tl!minislcrcll in 1"C1eurn uil, 1.67mLlkg. Gut segments IVcre
cxcis...'d ;Iml tied olT. then rinset! in 0.5% sudium taurucholate in normal
saline. DuplkU\c aliquuts IIf the rirtsings were mhm fur cUlInlinJ; nf
I"'HI anti Il'q I<lhd. Rccu\'cry is cllprcss ...'tI ilS a percentage Ilt'UOSC.
88
These results suggested that the dose of 1.67 mL com oil/kg. givcn
intraduodenally, exceeded the absorptive capacity of the slIlall intc.~line.
6.1.7 In intact animals, gasrric emptyir.g control!i the amount of lipid n.-achint; the
small intestine, hence absorptive mechanisms in the small int~liTlc lITC nm UMJ;dly
overwhelmed even by meals rich in fat. In order to examine OTA absorption in II
~ituation less artificial than Ihal of experiments (I) 10 (6l. nus were given OTA
by oral gavage. They had free access to water but were dcprivcll of foull starting 1K
or 24 hours prior to dosing. When rats starved for 18 hours werc givcn ("'HIOTA in
com oil, most of the dose was found in the s~omach six nours h,tcr (66.9. 72.11%); ill
rats starved for 24 hours. less (32.6 and 20,4%) was fOllnt! in the slmnaeh. IlmlmhJy
because gastric emptying cccurred sooner. In four mts given OTA in hicmhormlc.
whether starVed for 18 or 24 hours, essentially no I'HJOTA was fuund in the
stomach, six hoors post dose (0.15 ± 0.08"). Pretreatment with phenoharhillil
slowed intestinal transit; results in these rats were difficult 10 interpret. Figure 6.!l
shows the HPLC plots of chloroform extracts of stomach contents frum (a) and (II)
bicarbonate--<losed, (a) pretreated with phcnobar>:tal, and (cl oil-doscd rats;
(d) is standard 00, 4(S) and 4(R) 4-hydroxy OTA and OTA. In uil-dosed animals,
5· 10% of \;,e OTA recovered from the slomach wa~ in the form of Or... '''. mo.~t
likely formed by acid hydrolysis of OTA. Serum levels at six hours were ll'wer in
, Standard curves for OTA Kno Oa, shuwing cuncentratiun ,lgainM Il:"ak area
with the HPLC system used. are given in the ANlo:ooix un 1". ISS.
Figure 6.8
HilLe traces showing chlorofonn extracts of stomach contents six hours
nfter rals werc given OTA in sodium bicarbonate or corn oil
Rats were fasted for eighteen hours before receiving OTA, 288.8 fig/kg, by
oral gavage, in sodium bicarbonate groups (a) and (b), (a) pretreated with
phenobarbital, and group (c) in com oil. Water was provided lid lib.
Stomach contents were extractcd thrce limes in chlorofomt, dried under Nz,
picked up in methanol and filtered through a 0.45 Jtrn filler prior to HPLC
analysis. A Supcleosil LC 18 column, 3.3 em x 4.6 mm x 3.0 ~m was used
with a solvent system mcthanol:water, 80:20, and flow rate 1 mUminute.
Samples were delccl(:(J by nuorimeter, excitation 340 nm, emission 465 nm.
Trace (d) shows sl:lndard Oa, (4S) and (4R) 4-hydroxy OTA, and OTA.
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the IS-hour fastctl oil-dosed rals (6.7, 5.1 %) than in the 24·hour fasted oil·dosed rats
(16.5, 15.2%), or the bicarbonate-dosed rats (14.4 ± 2.1 %), Recovery of eH] label
at six hours in the distal small intestine and cecum plus colon was much higher in the
bicarbonate group (17.2 ± 4.9%) and the 24 hour-fasted oil-dosed rats (1.3.8,12.6%)
than in the oil-dosed IS-hour fasted rats (7.3, 5.7%). Figure 6.9 shows the HPLC
plols of chloroform c:draCIS of cecum plus colon contents in these animals:
6.9(a) refers to rats pretreated with phenobarbital, (a) and (b) were given OTA in
bicarbonate, (e) were given OTA in oil; (d) shows standard OTA and metabolites.
Less than 2% of OTA recovered from cecum and colon contents was in the
hydroxylated 4·QH form. Twenty-four hours after administration of eH]OTA, less
than I % or the dose was found in the stomach of either bicarbonate-dosed or oil-
dosed rats; less than 2 % was found in contents of the small intestine. Recovery of
(JH]OTA in ceC,lffi and colon contents, and in feces and urine is shown in Table 6.9.
The 24 hour recovery of OTA in cecum and colon contents, and in urine was
significantly more in bicarbonate-dosed than in oil·dosed rats (p = 0.05).
6.1.8 The kidney is known 10 be Ihe prime target organ of OTA, although it is
nol known with certainty whether OTA itself, or one or more of its metabolites is
ultimately responsible for the toxic effects seen. It therefore seemed worthwhile to
cKaminc OTA CKcreted in urine, and to confirlll the identity of metabolites described
by other workers. Figure 6.10 shows HPLC traces of aqueous and organic elttracts
of urine from a rat given [JH]OTA, 288.8 ~g/kg, in sodium bicarbonate, 1.67 mUkg.
Figure 6.9
HPLC traces showing chloroform exlracts of cecum and colon contenls
six hours after rats wert given OTA in sodium bicarbollnle or corll oil
Rats were starved for eighteen hours before receiving UTA, 288.8 ,.,.gJkg,
by oral gavage, in sodium bicarbonale, groups (a) and (b), (a) pretreated
with phenobarbital, and group (c) in com oil. Water was provided uti Jib.
Cecum and colon contents were extracted three times in chlorofonn, dried
under N1 , picked up in methanol and filtered through 0.45 ,.,.m filters prior
10 HPLC analysis. A Supelcosil LC 18 column, 3.3 em x 4.6 mm x 3.0 p.rn
was used with solvent system methanol:water, 80:20, now ratc I rnUminutc.
Samples were detected by nuorirneter, excitation 340 nm, emission 465 nffi.
Trace (d) shows standard 00, (45) and (4R) 4-hydroxy OTA, and OTA.
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Table 6.9
Recovery of rHlOTA from contents of large intestine, ilnd from
feces and urine in the 24 hours after oral administratilJlI of OTA
fH10TA vehicle bicarbonate
0=3
COfn oil
n =4
Recovery of [3H} label
(expressed as % dose)
Cecum and colon contents 11.4 ± 1.5% ...
Feces 8.9 ± 5.2%
Urine 7.6 ± 2.5% ...
Total excretion in feces and urine 16.5 ± 2.9%
6.1 ± 1.2%
7.3 ± :t6%
3.1 ± 0.9%
10.4 ± 4.3%
eHjOTA was administered orally in sodium bicarbonate or corn oil, al a dose
of 288.8 J.lglkg, - 2.3 pCi/kg. Conlents were gently squeezed oul of the cecmll
and colon, which were then rinsed x 2 with I mL 0.5% sodium taurocholate in
normal saline, then x 2 with 1 mL 50 mM sodium bicarbonate. Contents and
washings were homogenize(J, brought \0 pH 2.0 and extracted x 3 in chloroform.
Feces were similarly extracted. Recovery is expressed as a percentage of dose.
Values given are means ± so.
'" denotes a significant difference, p =: 0.05 in recovery of [JH] label
between rats given OTA in bicarbonate and those given OTA in corn oil.
Figure 6.10
HPLC traces of organic and aqueous extr:.J.cls of urine
from a rat given rHjOTA, in sodium bicarbonate
eHJOTA, 288.811g/kg, in sodium bicarbonate, 1.67 mUkg, was given
intraduodenally. Overnight bile was rein fused. Urine was acidified,
then extracted three times in chloroform. The organic extract was dried
under N1, and the aqueous extract was freeze-dried. Samples were picked
up in methanol and passed through a 0.45 14m filter prior to HPLC analysis.
A SupelcosillC 18 column, 3.3 cm x 4.6 mm x 3.0 p'm, was used with
solvent system methanol:water, 80:20, and flow rale I mUminutc.
Samples were detected by fluorimeter, excitation 340 nm, emission 465 nm.
0.5 ml fractions eluting from the fluorimeter were collected for counting of
[lH] label. Radioactivity is shown - superimposed on the HPLC trace.
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Recovery of (3H] label from 0.5 mL fractions of the eluant from the fluorimeter is
shown superimposed on the HPLC plot. There are many fluorescent pigments in
urine, and it proved difficult 10 use a volume of extracted urine small enough to give
sharp pe<;ks on HPLC while ensuring that adequate amounts of [JH] label were
present in the fractions collected. Urine acidified to pH 2 was extracted three times
in chloroform: when urine was first produced, 80% of the orA excreted was in the
form of water*solublc metabolites. If the urine was incubated at 37"C for thirty
minutes or allowed to remain at room temperature for an hour, the percentage
of waler-soluble metabolites dropped to 70%, and if left at ~ 4°C overnight, to 60%,
presumably because conjugates of OTA underwent spontaneous hydrolysis.
Extfficlion and freeze-drying of aqueous samples probably resulted in some loss
of water-soluble metabolites.
Elimination ofOTA occurs by excretion in urine and feces, so to Quantify
the efficacy of urinary excretion in rats, a dose slightly over ten times that previously
used, was given to Wi~tar and Sprague-Dawley ralS, two of each strain. Figure 6.11
shows thc six day recovery of eHlOTA in the urine of these animals, after receiving
a single oral dose of [JH]OTA, 3 mg/kg, in bicarbonate 1.67 mUkg. Approximately
2.6% was excreted in urine in the first six hours after dosing. In six days, about
13.7% of the administered dose was excreted in urine.
• 0 W;"l:or r"h.
• U SI'n'l:,,,,-lI,, .. Io,,\, r:ot~
o - ------r----,.------'~-I- I
o ~~ ~"72 1211
Figure 6.11
Six day recovery of [3H]OTA in urine of four rats given
a single dose of [3H]OTA in sodium bicarbonate
Rats were given [lHJOTA, 3 mg/mL, in sodium bicarbonate,
1.67 mUkg, by oral gavage. Urille was collected for six days.
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6.1.9 When lymph, serum and bile samples were acidified prior to extraction,
protein, associated with eHjlabel (:<!: 70% in the case of lymph), precipitated at the
aqueous/organic interface. HPLC analysis of cx.tracted samples showed that UTA
was carried in the parent form in lymph, Figllre 6.12, and serum, Figure 6.13.
6.2 Tn vitro studies
6.2.1 To gain a better understanding of how OTA partitions between the aqueous and
lipid phase in gut contents, we examined part,ilion of eH]OTA between chloroform or
com oil and potassium phosphate buffer, as a function of pH. The percentage of OTA
in the two phases (1 mL of each) was equal at =: pH 7.1 when chloroform was used
as the organic solvent, and 6.4 when com oil was used, Figure 6. 14.
The characteristiC Iluorcscence of OTA under ultraviolet light was clearly seen in the
organic or aqueous phase, depending on pH. Counting of eH] label confirmed the
partition as observed visually, and measurement of fluorescence (excitation 340 nm,
emission 465 nm) in the aqueous phase of the potassium phosphate buffer/com oil
partition followed the same trend as the radioactivity measurements.
6.2.2 To COnfil'll the pK. of tile phenolic hydroxyl group at position 8, OTA
solutions in phosphate buffer were scanned between 300 and 400 nm, as shown in
Figure 6.15. The peak at 332 nm represents the protonated phenolic hydroxyl group,
and the peak at 380 nm, the unprotonated form, plotted as a function of pH. The
extinction coefficient of the unprotonated form of the phenolic hydroxyl group was
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figurc6.12
HPLC tnlcc or chlororonn c"trllcl or lymph
Rats w~re given OTA intradullllenally, 28K.S IlgfmL,in ~nru llil 1.67 mLfkg.
Lymph WliS bruught w pH 2, lind cxtr<l~lctJ thrcll timc.\ in ~hIClru1iJrll\. It was
dried under N2, f11ck~d up in methanollLnd liltercll thrUl,~h II AS lUll li1ter
prior III HPLC analysis. An LC 18 3.3 ~11Ill, 4.6 mm ll, 3.0 lim cc,lumn was
used with a solvent system of mtlhallOl:W<llllr, 80:20, !lllW rati,: 1111l.1minutll.
Sampl~ were detected by nuorim;;.~r, ex~itatiun 340 nm, cmis.\iun 46S nm.
(a) shows a sample uf lymph from a contrul ral; (b) snuwJ lymph frum thll
rat given OTA; (c) is standard OTt..
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Figure 6.13
HPLC truce of chloroform extract of senlill
Rliis wcre given OTA by UTili gavage, 288.8 ~glIlIL.in corn oil 1.61 mLlkg. Serum
wa.~ ubtainL"t! hy l\llowing him!!.! drawn (Will the tlcsccnding aorta III st.IOU at ruum
1ClIlllcratU(C for une hour, then centrifuging it for 10 minUlcs at 250 g to prccipitllte
(Lod hluml cells. Serum WiL~ thcn witlllJrawn by piptlUe. It was bruught to pH 2, and
c;.;trilctclllhn:c limes in chlumfhrm, tlried under N~, pickoo up in methanul and fillered
thruugh 1\.45 JAIlI tiller prior tu HPLC analysis. An LC 18 3.3 em x 4.6 mill Jt 3.0 ~m
colUlll1l WillI used wilh asulwnt system ofmethilnol:water, 80:20, tluw (lIle ImLlmin.
Sample~ were detected hy Iluurimtller, excitation 340 nm, tllllission 465 nln.
(a) ~erllm frum a cllntrol rat; (b) ~erllm frum a rat given OTA; (c) OTA stamlard
,--- ~
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Figure 6.14
Partition of eHjOTA between aqueous and organic solvents liS a fllnction uf 1)11
[lH]OTA was partitioned between chloroform (-.) or com oil (.t.) and potassium
phosphate buffer (lJ) at a range of pH from 2.5 \I) 8.5 DClails arlJ giwn in Maturials
and Methods. Chloroformlhuffer partition is shown in 6.14.lt, and Ctlrn oil/hutl'lJr partition
in 6.14.b, Values shown are IlHI counts in thlo\ aqulo\(Jus arn.l organic phast:.~, IJxprl.!.~scU a.~
a perclo\ntage of 10lal I'Hjlabel recovered, where n :: 2 at each pH value, Fluorl.!.~ccnclJ
values ····D···· (excitation 340 nm, emission 465 nm) in the aqueous phase (diluted x 5)
of the cQrn oil/buffer partition are shown on the ordimlle on a scale of 0 . 200.
• AI, "b>.,,~~ al ~l\Il "n,
o A1, "b.,,~~ at 3~2 ",n
/~/
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Figure 6.15
Absorbance or OTA in phosphate burfer at 332 and 390 nm
OTA, 8.3 ~M, was dissolved in potassum phosphate buffer, 0.1 M, al a range
of pH from 5.010 10.5. Solutions were scanned between 300 and 400 nm.
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nearly three times as great as that of the protonatcd form, and therefore valucs for
the unprotonated form, given by absorbance readings al 380 nm, were llSCtlto
calculate the pK. This was idenlifierl as being approximately 7.15, the pH at which
the height of the peak was half ils maximum valuc. This value is slightly higher
than that recorded by Pilaut (26). who look the pH (7, I) at which lile two pc.,ks
were of equal height, or Chu [27], who reported an average vallie (7.04).
6.2.3 It seemed possible that OTA in bile and urine mighl be conjugated wilh
glucuronide, so attempts were made to synthesize OTA glucuronide, using UDPGA
with UDP-glucuronosyl transferase present in livcr microsomcs. Although thc
system worked well to glucuronidate p-nitrophenol, there was no evidence of OTA
glucuronide formation. When urine and bile were incubated wilh ,B·glucuronidase,
no difference was seen on thin layer chromatography betwccn exlracts of smnplcs
treated with enzyme and the control samples without enzyme. Phenolphthalein
glucuronide in the same system was readily hydrolysed to liberate phcnolphthalein.
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6.3.1 Summary or in vil'O experiments:
To observe uptake in
organs 12 hours after
eH]OTA in NaHCOJ
was given to rats intra-
duodenally, with bile.
2. To observe the time-
dependent load of
(lHJOTA in serum,
bile, liver and kidneys
6, 12, 18 and 24 hours
after OTA in NaHCOJ
was given intra-
duodenally with bile.
3. To observe [lH]
appearance in bile
and lymph over 7
hours after [lH10TA in
NaHCOl or com oil was
given intragastrically.
4. To determine whether
phenylalanine given
intragastrical1y at the
same time as [JH]OTA
affects OTA absorption.
(lH]OTA uptake was seen in liver (- 2.7% of dose),
kidneys (- 0.5%), lungs (- 0.4%0), pancreas
(- 0.3%) and epididymal fat (0.1 %). Over the 12
hours, 7.2% of dose was excreted in urine and 20.5%
was secreted in bile.
Recovery of (lH]OTA in serum and organs decreased
with time, as did the amount collected in bile over the
last 6 hours of each experiment. Although the total
amount of (lH]OTA was higher in liver than in kidneys,
uptakelg tissue was higher in kidney.
(lH] label appeared in bile and lymph within 15 minutes
of (lH]OTA administration, and reached peak values
within one hour. More [lH]OTA was recovered in bile
when NaHCOJ was the vehicle, and conversely, more in
lymph when the vehicle was com oil.
Recovery of [lH10TA in bile was minimally depressed in
the presence of phenylalanine. Uptake of [lHJOTA in
lymph was not affected by simultaneously administered
phenylalanine.
5. To note any differences
in uptake of [JH]OTA
depending on site of
administration (stomach
or duodenum);
to observe the effect
of vehicle (NaHCOJ or
com oil) when OTA was
given intraduodcnally,
and when com oil was
used, to investigate
the role of bile.
6. To observe the uptake
of [l4C] and [JH] in
lymph of rats given
[JH)OTA in corn oil
enriched with
[14C]trilinolein, and
following centrifugation
of lymph, to observe the
distribution of radio-
labels in chyJomicrons,
VLDL and infranatant.
To ascertain how much
of the dose remains
within the digestive
tract 6 hours
after administration.
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As with (3), recovery of (JH} label in bile was higher
when the vehicle was NaHCOJ; with intraduodenal
administration, this difference was significant at all time
points. Similarly, recovery of [JH] label in lymph was
enhanced by administration in corn oil; the diffcrencc was
significant from I \4 hours onwards. When [lH]OTA W<lS
given in corn oil withotlt bile reinfusion, uptake of ("'HI
label in lymph was not greatcr than that seen when
NaHCOJ was the vehicle; there was no difference in Ihe
appearance of [JH) label in bile when corn oil was Ihc
vehicle whether or not bile was rein fused. The increased
uptake in lymph when com oil was the vehicle may have
been partly due to increase in lymph now, but micellar
solubilization in mixed bile salt/lipid micelles was most
likely the principal mechanism enhancing uptake in lymph
[JH] label appeared in lymph within 15 minutes of dusing,
and by two hours most of the [lH)OTA transported in
lymph had been recovered. [14C] uptake started slowly
and proceeded throughout the six hour experiment.
Chylomicrons appeared later than expected, at - one
hour. Less than 5% of [lHJOTA was found in eilher
ehylomierons or VLDL: 90% was seen in the infranatant.
Approximately 60% of [I~CJ was in chylomicrons, and
- 34% was in VLDL. Usually, > 80% of unsaturatrAl
long-chain fatty acid is found in ehylomicrons, so this
unusual ratio suggests that lipid handling by the
monoglyceride pathway has been impaired. 30% of
administered [JH] and 22% of ['4C] was found in the
distal gut: some of this may have been absorbed and
secreted back into the gut, but some may have passctl
through the gut without being absorbed.
7. To observe the effect of
corn oil on the rate of
gastric emptying of an
oral dose of [lH]OTA,
and to measure
[lH)OTA in different
regions of the gut lumen
and tissues following
oral administration
of rHJOTA in either
NaHCOJ or com oil.
8a To examine the
excretion of OTA in
urine, and to confirm
the identity of
metabolites seen in
urine. To relate (JH]
label in chloroform and
aqueous extracts of
urine of rats given
CH]OTA to fluorescent
peaks seen on HPLC
(excitation 340 nm,
emission 465 nm).
8b To quantify urinary
excretion of OTA in
Wistar and Sprague-
Dawley rats given
["HIOTA in NaHC01.
9. To examine the form in
which OTA is carried in
lymph and serum.
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Corn oil markedly delayed gastric emptying. Six hours
after dosing, no OTA remained in the stomach when
NaHCOJ was the vehicle, but between 25 and 70% of the
dose remained (depending on duration of fasting prior to
dosing) when corn oil was used. In 18 hour-fasted, com
oil rats, in whom 70% of dose was found in the stomach,
serum levels were low, suggesting that absorption from
the stomach, if it does occur, takes place slowly.
Recovery of (lH] label from the distal intestine of these
rats was < lh of that seen in either 24 hour·fasted oil·
dosed Tats in whom 25% of dose remained, or of the
bicarbonate-dosoo rats, in whom no OTA was found in
the stomach. 5· :0% of OTA found in stomachs of oil-
dosed animals was in the form of OQ'. 24 hours after
OTA was given, no OTA was found in the stomach of
any rat. Of OTA found in CHCll extracts of cecum and
colon contents, less than 2% was 4-0H-OTA.
When urine at pH 2 was immediately extracted in
chloroform, 80% of OTA was in thc form of water~
soluble metabolites; if extraction of samples was delayed,
the percentage of OTA which appeared in the aqueous
fraction was lower, probably because OTA conjugates
underwent spontaneous hydrolysis. HPLC analysis of the
chloroform extract gave peaks corresponding with
standard OTA and 4(R) 4-0H OTA, as well as an earlier
unidentified peak. In the aqueous extract, peaks
corresponding with Oa and 4(5) and 4(R) 4-0H OTA
standards were seen, and some small unidentified peaks.
PH] label in HPLC effluent agreed with parent OTA
peaks in organic and aqueous extracts, and with Oa and
4(R) 4-0H OTA standards in the aqueous extract.
There was no difference in rates of excretion of OTA
between Wistar and Sprague-Dawley rats. Approximately
2.6% of dose administered was excreted in the first six
hours, but the rate of excretion feU aftcr that so that
cumulative excretion in urine at 6 days was 13.6%.
OTA was tighlly bound 10 prolein in bolh lymph and
serum. HPLC analysis showed that unbound OTA was
only found in the chloroform extract, and was only seen
in the parent form.
6.3.2 Summary of in I'itro experimcnts
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2.
To examine (he partition
of OTA between organic
and aqueous media as a
function of pH.
To observe protonation
of lhe phenolic group of
OTA, by scanning its
absorbance between 3W
and 400 nm.
At low pH, OTA was (ound in the organic phase.
and as the pH rose, it was increasingly found in
the aqueous phase. The percentagc of 01'A was
equal in the chloroform and aqueous phases at -
pH 7.1, and in the com oil and aqueous phases al
- 6.4. Fluorescence matched radioactivity.
The pK. of this group, based on half the
maximum peak hcight of the unprotonated (orm
of the phenolic hydroxyl group. was found to
be approximately 7.15.
7. DISCUSSION
ThP. physical characteristics of OTA playa role in both absorption and
excretion. TIle pK.s of the phenylalanine carboxyl group and the phenol are critical
in determining the degree of ionization of OTA in the different parts of ihe
gastrointestinal tract. I" yjvo, pH is regulated by secretion of HCI into the stomach,
and bicarbonate into the duodenum; in the jejunum, bicarbonate is absorbed while H·
ions are pumped into the lumen of the gut. Thus pH is maintained in a dynamic
fashion at levels characteristic of each region. It was not possible to recreate this
system with HCI and bicarbonate in yjfro and therefore p:losphate buffer was used to
provide a stable range of pH. Such stability, while useful in demonstrating the effect
of pH, lacks the ncxibility of the physiological system.
Based on the shift in the absorbance peak of orA with va:-ying pH, in the
experiment described in 5.7.2 and 6.3.2(2), the pK of the phenolic group orurA
was found to be 7.15; this value is slightly higher than that found by Chu [27], who
identified the pK of this irouP as 7.04 (using KCI, and adju$ling the pH with Hel),
and Pitou( [26J, who found 7.1 (using phosphate buffer). On the other hand, Gallier
Cf 01. reported two constants, pK1 at 6.75 and pKz at 10.25, which they attributed to
thc carboxyl and phenol groups respectively [28]. The accepted pK value for the
carboxyl group of phenylalanine alone is 2.58 (144J. and it seems improbable that
its pK in OTA could be modified by more than four pH units as a result of the
linkage of phenylalanine with methylisocoumarin. It appears more likely that
Ualtier's pK1 refers 10 the phenolic group. It may be that the pKz they described
reflects the opening of the melhylisocoumarin lactone ring, which would be expected
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at high pH. Titration of OTA against acid and alkali. with the intention of
identifying the pK. of the carboxyl group, was unsuccessful. OTA;s only sparingly
soluble in aqueous media at acid pH, when it is largely protonated and nun-ionized.
In the experiment described in 5.7.1 and 6.3.2(1), 50% partition of OTA between
chlorofonn and phosphate buffer, and between corn oil and phosphate buffer,
occurred at pH 7.1 and 6.4 respectively (Figure 6.15). The partition conslant at
any pH is the ratio between the prolonated form dissolved in the organic phase, ami
that dissolved in the aqueous phase, of which some is ionized and some protonalcd,
depending on the pK,.
Partition of OTA in a two-phase system such as phosphate buffer and COrll
oil is relevant to its distribution in stomach contents, bUI less so whcn partition
in duodenal contents is considered. Given the pH prevailing in the stomach, OTA
in a meal which contains lipid will 10 a large extent be found in the oily phase.
When food reaches the duodenum and the pH starts to rise, OTA will increasingly
partition into the aqueous phase; in the presence of bile, the aquL'Olls phase will
contain a variety of lipid aggregates, including mixed bile sail/lipid lI1icellc.~ and
bilayer vesicles. Depending on the relative concentrations of bile salts, phospholipids
and lipids, various lipid phases may co-exist, and these can be expected to change as
digestion and absorption proceed [114]. It is probable that OTA is associated with
some or all of the lipid/bile sail aggregates; we have shown that the presence of bile
enhances uptake into lymph when corn oil was used as the vehicle for OTA.
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In vitro, partition of polycyclic hydrocarbons in simulated intestinal contents
has been examined by adding the xenobiotics to a sonicated mixture of buffered
solutions of bile salt with triglyceride, monoglyccride, fatty acids and phospholipid.
Solubility in the aqueous phase was attributed to true micellar solubilitatlon [145].
It would be interesting 10 observe the distribution of OTA in such a system.
The importance of the pk. of the phenolic hydroxyl group at C. is related
to toxicity of the OTA molecule, which appears 10 be dependent on ionization of this
group (146]. The chlorine atom at Cj enhances ionization of the hydroxyl group
at C. by delocalizing electrons of the isocoumarin ring; ochratoxin B. the ochratoxin
which lacks the chlorine alom, is at least len times less toxic than OTA.
The pH in the stomach is approximately 2.0, probably a Iiltle higher if
buffered by food. OTA will therelore be in the protonated form, and the main
mechanism of transfer into the absorptive cell, like that of other weak electrolytes,
is likely to be passive diffusion of the non-ionized form aCr'Jss thfJ lipid membrane
[147]. Six hours post oral OTA administration, higher levels of OTA were found
in stomach tissue than in intestinal tissue (5.5.7 and 6.1.7). Higher OTA levels in
stomach tissue were also noted by Gallier [139] who concluded that gastric absorption
of OTA is of major importance. It is more likely that OTA found in gastric tissue
renecls a slow process occurring over a relatively small area; in quantitative terms
gastric absorption is probably less important than absorption through mucosa of the
small intestine. In two oil-dosed animals, given OTA by oral gavage after fasting for
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18 hours, about 70% of the dose was found in the stomach six hours after dosing;
in six hours following OTA administration in these animals, only 30% of the dose
had left the stomach, either by absorption or by gastric cmptying; approximately 7%
of this was found in the distal gut lumen, and 6% was carried in thc serum, In two
oil--d.osed animals starVed for 24 hours before dosing, approximately 73% of the
administefl'-d dose had passed out of the stomach; 15% was recovered from the distal
lumen, and approximately 16% was found in serum, In four bicarbonatc-dosed
animals, 99% of the dose had Icft the stomach, 17% was found in the distnl lumen
and serum OTA accounted for 12,1 ± 2,4%, Excretion in urinc was similar in all
three groups: 1,8%, 2.1 %, 2,0%, These rc.sults could be explaincd by ,~'ow
absorption in the stomach and faster absorption occurring ovcr the greater surfacc
area of the small intestine, This would be in agreement with the findings of
Kumagai and Aibara who demonstrated that the primary site of OTA ab:;orption is
the small intestine, with maximum absorption occurring in the jejunum [1281,
Food entering the duodenum is initially acid but is soon neutralized by
bicarbonate:; OTA will thus become increasingly ionized and soluble in the aqueous
phasc, depending on the prcvailing pH. In the proximal jejunum, the pH of the
luminal contents varies from 6.8 - 7.2, but a more acid mieroclimatc cxists close to
the mucosal surface [117], because H-+ ions are secreted as bicarbonate is reabsorbed.
The low pH of this region close to the mucosa is maintained by a mucopolysaccharide
coating, approximately 700 Jolrn deep, which is secreted by epithelial cells [116],
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Kumagai showed increased uplake of OTA by the everted jejunum as the pH of
the incubation medium was reduced from 8.8 to 7.4 to 6.8 (148], suggesting that
increased protanation of OTA consequent on the fall in pH enhanced uptake in
Ihis model. In the ileum, where bicarbonate is actively secreted into the lumen in
exchange for chloride ions and the pH is 7.0 - 8.0, OTA is ionized and therefore
nOI so readily absorbed across the lipid membrane.
Intestinal absorption of neutral amino acids has been shown 10 involve specific
carrier-mediated energy- and Na-t-dependent system~, which show specificity for the
L-isomers [140]. OTA might be transported in pari by Ihis means, in which case one
might expect competitive inhibition of OTA absorption by phenylalanine, as suggested
by Delacruz and Bach [138]. On Ihe other hand, Roth el al [129] reported lhal
gastric abSOrplion of OTA in mice was enhanced in the presence of phenylalanine.
The experiment described in 5.5.4 and 6.1.4 offers no evidence to support either of
these hypotheses: phenylalanine concurrently administered intragastrically in a molar
concentration to times that of orA did not significantly affcct OTA uptake in
Sprague-Dawley 1"21$. It is possible that the low molar concentrations used in this
experiment (0.4 mM OTA and 4.0 roM phenylalanine. in 0.5 mL vehicle) did not
approach the capacity of the carrier mechanism. and therefore one cannot rule out
OTA transport by this means.
The absorption of foreign compounds is influenced by a number of factors.
including the rate of passage through the gut. The presence of fat markedly delays
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stomach emptying: in intact rats. a dose of OTA which left the slomach fairly
quickly .vhen it was given in bicarbonate took belween 12 and 24 hours when it
was administered in com oil (5.5.7 and 6.1.7). The profiles of ['HJ uptake in lymph
in operated rats hydraled at 3.1 mUhour were similar whether OTA in corn oil was
given into the stomach or the duodenum (experiments 5.5.3 and 5.5.5, with results
described in 6.1.3 and 6.1.5, and Figures 6.4 and 6.5); it is probable that Slomach
emptying occurred more rapidly in these well-hydrated rals than in orally-dosc<l
intact rats allowed free access to fluid.
Solubility in lipids enhances transport Ilia the lymphatic system, particularly if
the vehicle, like corn oil, consists of triglycerides containing long chain unsalulfltcd
fatty acids [149J. On the other hand, the enterocyte may lllodify lipid·soluble
parent compounds 10 produce more polar metabolites which arc more readily carried
in portal venous blood. The physical form of a compound or its vehicle lllay affect
both the rate and extent of absorption: many studies of fat absorption have llsed an
emulsified test dose, thus immediately providing a large surface area for lipase action.
OTA in the experiments deseribed here was dissolved in non-emulsified corn oil, and
therefore lipolysis would start more slowly. Recovery of25% of (l4C] label in the
distal lumen after intraduodenal administration (5.5.6, 6.1.6 and Table 6.7) points \0
the inability of the small intestine to absorb a bolus of lipid which, hat! it been
delivered over some hours in an emulsified form, would have presented no difficulty.
The maximum capacity of the small intestine for fatty acid absorption is about
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500 ~mollhour (150J, equivalent to 0.88 g trilinolein over six hours.
Of the 29% of administered [lH] label recovered in distal intestinal contents, some
had passed through the intestinal tmet without being absorbed, and some had been
absorbed and then returned 10 the intestine by biliary excretion. Based on biliary
recovery of (JH] label from rats given eH]OTA in corn oil in experiments 5.5.3 and
5.5.5, (sec Tables 6.3 and 6.5) - 10% of the administered dose had been excreted
in bile. In retrospect, it is clear that the administration of a bolus dose of OTA in
non-emulsified corn oil resulte<l in lower absorption of bolh lipid vehicle and loxin,
whereas administration in sodium bicarbonate maximized absorption. This should
be borne in mind when recoveries of OTA are compared.
Blood now in the portal vein is much greater than mesenteric lymph flow (by
a factor of about 500) [151], so if a substance is partitioned between portal venous
hlood and lymph, as is the case with OTA, the lymphatic route is quantitatively less
important. In spite of these considerations, it is clear that the lymphatic route plays a
role in the transport of absorbed OTA. When OTA was administered intraduodenally
in bicarbonate, II % of the dose was recovered in lymph over 6 hOUrs, by comparison
with 20% when administered in com oil (experiment 5.5.5, Table 6.5).
Total recovery of label in lymph, bile, serum and urine was somewhat lower (41 %
compared with 49%) when com oil was the vehicle, but the important difference lay
in the route of absorption. The enhanced lymphatic transport of OTA when it is
administered in com oil may be due in part to the increased lymph flow which occurs
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when lipids are ingested. but Tables 6.6 and 6.7. which show the relationship betwccn
lymph now and OTA uptake, suggest that other mechanisms may also be involvro.
In the absence of reinfused bile, recovery of [JH]OTA in lymph was not
increased even in the presence of com oil (Figure 6.4, Table 6.5). Thus both lipid
and bile are necessary for maximum transport of OTA in lymph. lllis suggests the
incorporation ofOTA in mixed bile salt/lipid micelles (152] as an important
means of OTA transport to the en(eroeyle. TIle dual polar/non-polar structure of
OTA would be well suited 10 micellar solubilization, wilh the isocolll1larin ring
oriented towards the hydrophobic centre of Ihe micelle. Micelles facilil.atc pllSs<1gC of
lipid products, particularly long-chain fatty acids and cholesterol, aeros... the unstirrcd
water layer adjacent 10 the brush border. This ullslirmJ water layer appcaD to be
part of the same phenomenon as tile acid microclimate (117) and mucopolysaccharide
coating [116] described by Lucas and Shiau. The pH of this layer. thought 10 be
about 5.4, favours both micellar diffusion through the aqueous mooium and micellar
dissociation as fauy acids within the micelle become more protonalcd and therefore
less soluble in bile salt micelles [118]. Lipid products are released close 10 the
membrane of the absorplive cell. and can diffuse into Ihe membrane and so be
absorbed. If OTA is carried in mixed lipid/bile salt micelles, similar conliidemtions
might apply. In the absence of dietary lipid, bile salts if present above the critical
micellar concentration aggregate with biliary phospholipid and cholesterol to form
micelles and other similar structures smaller than the mixed bile sail/lipid miccllc.~
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(114); OTA is probably 10 some extent associated with these aggregates. In the
absence of bile, approximately 10% of the administered dose still appeared in lymph
crable 6.5), so it seems that OTA can also traverse the unstirred water layer by itself,
unassociated with micelles. Micellar solubilization in mixed bile salt/lipid micelles
appears to increase the amount carried in lymph by 9 • 10%, i.e to double ii, al the
expense of portal venous transport. OTA carried in association with lipid in mixed
bile salt micelles seems destined 10 appear in lymph. It is possible that the higher
uptake of OTA/mL of lymph when both lipid and bile are present is 10 some extenl
due to increased erriciency of OTA transport across the unstirred water layer.
In spite of the association of OTA with lipid durin!! absorption into the
cntcrocytc, it is not exported into lymph with lipid in chylomicra or VLDL, but is
clearly associated with the heavier components of lymph, presumably serum proteins
(experiment 5.5.6, results described in 6.1.6 and Figure 6.7). Probably because it
was administered in non-emulsified corn oil, OTA uplake occurred at the onset of
lipolysis, rather than during the steady state phase of lipid processing (Figure 6.6).
The profile of centrifuged lymph shows a distribution of ('4C]trilinolein in
chytomicrons and VLDL was different from that expected ( > 80% in chylomicrons
following infusion of emulsified long-chain unsaturated fatty acid) with only 55% and
65% in the (I + 2) and (4 + 5) hour samples respectively. This may reflect tn some
extent the slow onset of lipolysis when a bolus dose of non-emulsified com oil was
given after 24 hours of fasting, with consequent prolongation of activity of the
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a·glycerophosphate pathway of lipoprotein (VLDL) synthesis. Alternatively,
it may indicate that OTA impairs triglyceride handling by the moooglyccri~
(chylomicron-synthesizing) pathway. The delayed chylomicfOfI appearance lime
(greater than one hour, by comparison with the 13.6 minutes fl('ltcd by Too 11.53))
might be in keeping with this possibility_
An indication of OTA transport ~'iCl the portal vein is given by mCMurement
of [lH] label in bile. In the experimental preparation described here, when lymph
was collected from the main inte.~linallymphatic vessel, il was ilssumcd thnt no OTA
could reach the general circulation by the lymphatic route, i.I', that the contribution
of minor mesenteric lymphatic vessels was negligible. 11\e only roule by which OTA
could reach the liver and the general circulation was viu the portal vein. Por1al
venous transport can therefore be estimated by taking the sum of OrA recovery in
serum, bile and organs. Twelve hours after intraduodenal administration of OTA in
NaHCO} to bile fistula rats (experiment 5.1.1), we found approxilT'.ately 2.2" of the
dose in the liver, 0.5" in the kidneys and 0.4" in the lungs, (fable 6.1). Gallier
{127} demonstrated substantial uptake of {14C] label in muscle (12.0%), skin (11.1 %)
and fat (1.7%), wilh 2.6% in Ihe liver, 0.6% in the kidneys and 0.6% in the lungs,
(Iolal 28.6%) 6 hours after intravenous administration of [14C]OTA in NaHCOJ • Bile
and lymph were not withdrawn from the rats in his ellpcrimcrtls. Even allowing for
differences in ellperimental design, it is clear that both skin and muscle are important
depots of OTA. Organ uptake is related to serum levels: where Galtier gave 24% as
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the six hour (plasma) OTA load, we found 19.8 and 8.8% in the B+ and C+
groups respectively (fable 6.5). A conservative estimate of OTA distributed
to organs, including muscle and skin. in our system would be - 20% and 10%.
When OTA was given in sodium bicarbonate 38% of [lH] label was recovered in bile,
serum and urine (Table 6.5), plus (assumed) 20% in tissues. 11 % was recovered in
lymph, so that for the (lHJOTA recovered (- 70% of dose), the ratio of portal
venous 10 lymphatic transport was - 5:1. When com oil was the vehicle, 21.5%
wa.~ recovered in bile. serum and urine, plus 10% in tissues; 20% was recovered in
lymph. Thus for the 50% of dose recovered, portal:lymphatic ratio for oil-dosed rats
was - 3:2. No account has been taken of unabsorbed [lH]OTA in the C+ group.
Kumagai and Aibara studied OTA absorption in rats by isolating different
regions of the gut in siru, and injecting the test dose directly into the lumen [128].
They demonstrated that OTA absorption occurred most effectively from the jejunum.
They then studied the appearance of OTA in lymph and portal venous blood after
injection of OTA (I8 - 85 ~g in 0.3 mL Krebs-Ringer solution) into the proximal
jejunum. At the highest dose, fifty times as much OTA was taken up in the portal
venous system as in lymph, but at the lowest dose there was only a four-fold
difference. Kumagai and Aibara concluded that the primary roule of OTA absorption
is the porlal vein, but the lower the luminal concentration of OTA, the greater the
role played by the lymphatic route in absorption. The amount of OTA appearing in
lymph over the fir~t thirty minutes after OTA was given was less than 2% of the
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administered dose. Mean lymph flow in their series of 41 rals was 246 JlU10
minutes, whereas in our lymph uptake studies, rats with lymph flow less than 3.0 mL
over the first two hours (250 JtUIO minutes) were nol included in analysis of data, It
is possible that in the experimental system used by Kumagai and Aibara lymph flow
was to some exlent obstructed.
The mechanism of absorption of OTA I'ill the portal vein is nol clear. When
OTA is given in corn oil, recovery of [lH] in bile was not affected by the presence or
absence of reinfused bile (experiment 5.5.5, results reported in 6.1.5 and Table 6.5),
Thus it is probable in this case that a mechanism other than micellar solubilization is
responsible for the transport of OTA via the portal vein. It is known that a
substantial proportion of unsaturated long-chain fatty acids is lranslJOrted from rat
intestine in portal venous blood (154,155], particularly when absorption rates
are low. OTA might diffuse across the unstirred water layer in the ionized form,
as do short and a proportion of medium chain fatt)' acids. Passage across the lipid
membrane of absorptive epithelial cells would depend on the permeability coefficient
and the concentration ofOTA on the two sides of the membrane, assuming this is a
passive process. It is possible (but, based on chemical structure, unlikely) that OTA
might be bound in the cell by the fatty acid binding protein (122] or a similar carrier,
or it could diffuse in the free form, to pass out of the cell into blood capillaries which
drain into the portal venous system and so to the liver. In the circulatory system,
macromolecules in the serum bind OTA very efficiently and thus ereate the gradient
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necessary 10 facilitate passage of OTA across the membrane.
Elimination of foreign organic compounds and their metabolites occurs
through the complementary pathways of biliary and urinary excretion. In the rat,
organic anions of relatively low molecular weight « 3(0) are poorly excreted in
bile « 10% of dose), whereas those of higher molecular weight (> 5(0) are
predominantly excreted in bile. Organic anions of intermediate molecular weight
(350 - 450) such as OTA (m.w. 404) arc excreted extensively via both pathways
[156], In humans, appreciable biliary excretion of organic anions only occurs
when the molecular weight is above a1.oul5oo [157]. so it is probable that OTA is
to a large extent excreted in urine. with a smaller proportion excreted in conjugated
form in bile. The general rule holds true that urinary excretion is greatest for
compounds of low molecular weight, and decreases as molecular weight rises and
biliary excretion becomes more extensive. Biliary output of OTA reflects the
amount reaching the liver; initially this is a function of portal venous transport
but subsequently, because OTA persists in the serum long after the OTA has been
absorbed, there will be continuous low·level excretion in both bile and urine,
gradually depleting the level of circulating OTA. In the normal situation, biliary
secretions are subject to enterohepatic circulation, so that OTA and metabolites
excreted in bile are recirculated. Hydrolysis ('If OTA metabolites by anaerobic gut
nora in the cecum and colon would explain the high levels of parent QTA in these
samples. Recovery of (lH] label from the distal pans of the gut represents both
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unabsorbed OTA and OTA which has been absorbed and subsequcntly
excreted in bile.
The disparity of serum OTA levels (21 % or 9%) apparently dependent on
whether OTA was given in bicarbonate or com oil is most likely a consequence of
the experimental design (5.5.5, Table 6.5). When OTA is given intraduodenally in
corn oil, the lymphatic route assumes greater importance than when OTA is
administered in bicarbonate, and withdrawing all the mesenteric lymph mthcr than
aBowing it to reach the circulation clearly has a marked impact on serum levels.
The significance of lymphatic transport of substances absorbed from the
gastrointestinal tract is that xenobiotic compounl.>s are dclivered dircctly into the
general circulation via the thoracic duct, thus avoiding Mfirst-pass" hepatic
metabolism. OTA binding to plasma proteins ensures a long half-life. StojkoviC
ef al. [7IJ proposed that binding of OTA to low molecular weight (20,000) plasma
constituents might be a means of delivery of OTA to the primary target organ, the
kidney, because molecules of this size can pass through the glomerular membrane
where albumin could not. Busbee et al. suggested in the context of bcn7.0laJpyrcnc
metabolism that mesenteric lymph node cells and circulating lymphocytes in the
thoracic duct could be exposed to transiently high concentrations of xenobiotic
compounds transported in the lymphatic system [1581. This may contribute to the
immunosuppressive effects of OTA (76.159). The increased lymphatic transport
which accompanies lipid intake may thus enhance the toxicity of OTA.
CONCLUSION
This study points out the role of fat in influencing the absorption of
xenobiotics. Increased fat consumption is associated with an increased likelihood
of developing certain cancers, e.g. of the colon and perhaps also the breast.
Ingestion of OTA in com oil rather than sodium bicarbonate doubles the
proportion of absorbed OTA carried in lymph. This increased lymphatic transport
of OTA may contribute to the immunosuppressive effects of OTA by exposing
mesenteric lymph nodes 10 transiently high concentrations of the toxin. Lymphatic
transport bypasses the metabolizing enzymes of the liver, and unmetabolized OTA
is delivered directly into the circulation where it binds extremely strongly to serum
proteins, so prolonging the serum half-life. The Imdcity of OTA may therefore be
enhanced by ingestion in the presence of lipid.
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APPENDIX
10.1 Species Yariability or absorptive mechanisms The choice of rat as
the experimental animal was dictated by its convenient size, and because of
familiarity with the anatomy.
Extrapolation of results and conclusions to other species should be made
with caution because different species may vary in their ability to absorb specific
xcnobiotics. Metabolic handling [160], binding 10 serum proteins PO] and
sensitivity to toxic insult [161J vary from one species to another, and sometimes
from one strain to another. Activities of many enzymes vary with species [162],
strain [163], sex [164], and age [165J; these differences are often associated with
differing susceptibilities 10 mutagens [166]. Table 2.3, p.19 shows that pig and
dog are much more sensitive than rat to the acute effects of OTA ingested orally.
The activity of cytochrome P450 enzymes is greater in male rats, being influenced
by the balance of sex hormones. In human females, biotransforming ability can vary
during the menstrual cvcle and with use of oral contraceptives. Maturation and
ageing are associated witll changes in intestinal morphology and enzyme activity
which may affect absorption of specific substances [167,168,169]. Studies
of toxicity and carcinogenesis in animals have been extrapolated to predict risk in
humans [170J, but it is recognized that estimation of human risk from animal
studies is an imperfect science.
Interspecics variation in sensitivity to xenobiotics has been largely altributed to
1.51
differences in metabolic handling; differences in absorption have receivL'd
less attention. In a thoughtful discussion of ab~rption of foreign compounds.
Calabrese [171J describes some of the factors underlying interspecies differences:
variations in anatomy and physiology of the gastrointestinal tract, in enterohcpatic
circulation, and in the spectrum and extent of colonization by gut nora.
There are marked anatomical variations in the gastrointcstinal tracts of
ruminants and monogastric animals, and between various monogastric animals such
as rat and pig. Cellular localization of some enzymes, e.g. prcduodcnallipascs
[172] and acid phosphatase [173]. may vary. The pH in differcnt regions of
the gut varies, i!.g. the rabbit stomach is very acid. This affects thc degree of
ionization of weak electrolytes and thus the extent to whtch they are lipid-soluble.
Urine and bile are complementary pathways in the excretion of org.1.nic
compounds [156J; compounds excreted primarily in bile are polar, and their molecular
weights exceed a threshold value which depends on species: 325 (rat), 400 (guinea
pig), 475 (rabbit) and SOO (human) [174]. Biotransformation by phase I and phase
II reactions converts many compounds by conjugation with glucuronide or glutathione
to metabolites which meelthese requirements. In rats, compounds of molecular
weight below 350 are excreted predominantly in the urine, those with molecular
weights between 350 and 450 are eliminated by both roules, and compounds wilh
molecular weights greater than 450 are mostly excreted in bile (156). Biliary
excretion [175} and entcrohcpatic circulation of various drugs vary from one
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species to another, and arc influenced by age and sex. In a comprehensive
review of entcro-hepatic circulation of foreign compounds, Gregus and Klaassen
discuss the significance of inlerspedes variations [176J. Rat, dog and hen lend to
be more efficient biliary excretors than rabbit and guinea pig; biliary excretion of
acetominophen and chloramphenicol is ten- and twenty-fold greater in rats than in
humans. Biliary excretion and COleTa-hepatic circulation of OTA are probably less
in humans than in rats, and therefore the load of OTA which must be handled by
human kidneys is likely to be greater.
Variations in intestinal flora, related to differences in pH in the intestinal
lracl, and to diet, may result in differences in biotransformation of biliary metabolites.
Glucuronidcs are poorly absorbed, whereas hydrolysed to the parent compound they
are more easily absorbed . .a-glucuronidase activity of cecal microflora differs greatly
from one species to another, being very high in fowl, high in rat and sheep, and low
in cow, pig, cat and horse; it is higher in humans on a diet rich in meat, and
therefore high meat intake enhances reabsorption of xenobiotics excreted in bile.
High meat intake probably correlates with slower intestinal transit, whereas transit is
faster in individuals with a high percentage of fibre in the diet.
Conclusions from these studies of gastrointestinal absorption of OTA in mak
Sprague-Dawley rat are not necessarily applicable to female rats, to neonatal or old
rats, or 10 other strains or species, but the conclusion that a lipid-rich diet influences
the route of absorption is likely to be valid for humans as well as for rats.
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10.2 Radiolabeled Oebratoxin A {'H]OTA was purchased from Amersham UK.
Tritiated toxin was prepared by exposing aTA overnight 10 trilialed water in the
presence of a platinum catalyst, at approximately 80°e. This results in a gencml
exchange of tritium with hydrogen, which has been shown [177] to occur mainly
(81 %) in the phenylalanine residue, and less (19%) in thc Oct moiety.
The tritiated toxin appeared to be quite stable both during storage at -20°, _4° and
at room temperature over the lime frame of Ihe experiments, both in terms of its
radioactivity and chemical structure. Care was taken at all timcs to protect it from
light as it has been suggested that exposure to light may cause some degradation of
aTA to phenylalaume and Oa.
Lymph, serum, bile, and urine collected from rats given [J"I]OTA was
extracted in chloroform, and subjected to HPlC analysis as described on p.63.
OTA in lymph and serum was only seen in the parent form; estimation of OTA
using HPLC with known standards correlated fairly well with estimation by
measurements of radioactivity. Up to 70% of the radioactivity in lymph <lnd
serum samples was lost during extraction, much of it associated with protein which
precipitated when the samples were acidified. When extracts of bilc and urine wcre
subjected to HPLC analysis, several fluorescent peaks were observed, corresponding
with standard samples of Oa, (l) and (R) 4-0H OTA and parent OTA. There was
good correlation between the OTA peak and radioactivity counts of HPLC effluent,
but the correlation was less clear with Oct and 4-0H (see p.97).
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10.3 Radjolabe~d Irllinolein [14CJtrilinolein purchased from Dupont, Boston MA
was labelled with [14CJ in the carboxyl group of the linoleic acid residues.
10.4 Preparation or 1.006 g/mL density solution: [178]
Weigh 11.4 g NaCl and 0.1 g EDTA-Nal. transfer to a IL volumetric flask,
and add 500 mL HlO, 0.2 g Na azide and 1 mL N NaOH. Fill to IL mark, then add
3 mL H20. [NaCl];;; 0.195 M.
'''''i/O"- ~-·1·:::L(
'"00
~oo •
".
10.5 Oa and OTA standard curves
based 00 peak area reported on HPLC. 00 was obtained by renuxin~ OTA
with 6N HCI for 30 hours, as described by v,," der Merwc l'llil. [1791_
It was extracted in chloroform, dried over anhy<!rous sodium sulphate, and
chloroform was removed by evaporation under reduced pressure. Dissolved
in methanol it gave a single peak on HPLC. [OTA] was calculated usin~ the
absorption coefficient at 332 nm (6.33 mM-1) [134]. Standards were made up
in methanol. A Supelcosil LC 18 column, 3.3 cm x 4.6 mrn x 3.0 /-1m, was
used with solvent system methanol:water, 80:20, and now rate I mUminute.
Samples were detected by fluorimeter, excitation 340 nm, emission 465 nm.
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